# EDGAR Filing Document

**Accession Number:** 0001892492
**File Stem:** 0001493152-25-012996
**Filing Date:** 2025-9
**Character Count:** 171141
**Document Hash:** 7edae16a0a0d94a84bc3e83177f48a7c
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001493152-25-012996.hdr.sgml**: 20250910

**ACCESSION NUMBER**: 0001493152-25-012996

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 16

**CONFORMED PERIOD OF REPORT**: 20250910

**ITEM INFORMATION**: Entry into a Material Definitive Agreement

**ITEM INFORMATION**: Financial Statements and Exhibits

**FILED AS OF DATE**: 20250910

**DATE AS OF CHANGE**: 20250910

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Eightco Holdings Inc.
- **CENTRAL INDEX KEY:** 0001892492
- **STANDARD INDUSTRIAL CLASSIFICATION:** SHORT-TERM BUSINESS CREDIT INSTITUTIONS [6153]
- **ORGANIZATION NAME:** 02 Finance
- **EIN:** 872755739
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-41033
- **FILM NUMBER:** 251306153

**BUSINESS ADDRESS:**
- **STREET 1:** 101 LARRY HOLMES DR.
- **STREET 2:** SUITE 313
- **CITY:** EASTON
- **STATE:** PA
- **ZIP:** 18042
- **BUSINESS PHONE:** 888-765-8933

**MAIL ADDRESS:**
- **STREET 1:** 101 LARRY HOLMES DR.
- **STREET 2:** SUITE 313
- **CITY:** EASTON
- **STATE:** PA
- **ZIP:** 18042

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Cryptyde, Inc.
- **DATE OF NAME CHANGE:** 20211105

?xml version='1.0' encoding='ASCII'?

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

**FORM 8-K**

CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d)

OF THE SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported): September 10, 2025

**EIGHTCO HOLDINGS INC.**

(Exact name of registrant as specified in its charter)

---

| | | |
|:---|:---|:---|
| **Delaware** | **001-41033** | **87-2755739** |
| <br> (State or other jurisdiction<br> of incorporation or organization) | <br> (Commission<br> File Number) | <br> (IRS Employer<br> Identification No.) |

---

**101 Larry Holmes Drive**

**Suite 313**

**Easton,** **PA** 

(Address of principal executive office) (Zip Code)

**(888) 765-8933**

(Registrants' telephone number, including area code)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered |
| **Common Stock, par value $0.001** | **OCTO** | **The Nasdaq Stock Market LLC** |

---

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter)

Emerging Growth Company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

**Item 1.01 Entry into a Material Definitive Agreement.** 

On September 10, 2025, Eightco Holdings Inc. (the "***Company***") entered into a Sales Agreement (the "***Sales Agreement***") with R.F. Lafferty & Co., Inc. (the "***Agent***"), pursuant to which the Company, from time to time, may offer and sell shares (the "***ATM Shares***") of its common stock, par value $0.001 per share (the "***Company Common Stock***"), through or to the Agent having an aggregate sales price of up to $2,700,000,000 (the "***ATM Offering***").

Subject to the terms and conditions of the Agreement, the Agent will use its commercially reasonable efforts to sell the ATM Shares from time to time, based upon the Company's instructions. The Company has provided the Agent with customary indemnification rights, and the Agent will be entitled to a commission of up to 3.0% of the gross proceeds from each sale of the ATM Shares effectuated through or to the applicable Agent selling the ATM Shares.

Sales of the ATM Shares, if any, under the Agreement may be made in transactions that are deemed to be "at the market offerings" as defined in Rule 415 under the Securities Act of 1933, as amended. The Company has no obligation to sell any of the ATM Shares and may at any time suspend offers under the Agreement or terminate the Agreement.

This description of the Agreement does not purport to be complete and is qualified in its entirety by reference to the Agreement, which is attached hereto as Exhibit 1.1 and incorporated by reference herein.

The Company Common Stock to be sold under the Agreement, if any, will be issued and sold pursuant to the Company's automatic shelf registration statement on Form S-3 (File No. 333-[•]) (the "***Registration Statement***"), which was filed with the Securities and Exchange Commission (the "***SEC***") on September 10, 2025. On September 10, 2025, the Company filed a prospectus supplement to the Registration Statement with the SEC in connection with the offer and sale of the ATM Shares pursuant to the Agreement.

This Current Report on Form 8-K shall not constitute an offer to sell or a solicitation of an offer to buy any shares of Company Common Stock nor shall there be any sale of shares of Company Common Stock in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or other jurisdiction. The legal opinion of Winston & Strawn LLP relating to the legality of the issuance and sale of the ATM Shares pursuant to the ATM Offering is attached as Exhibit 5.1 to this Current Report on Form 8-K and is incorporated by reference herein.

**Item 9.01 Financial Statements and Exhibits**

***(d) Exhibits.***

---

| | |
|:---|:---|
| Exhibit No. | Description |
| 1.1 | [Sales Agreement, dated as of September 10, 2025, by and among the Company and R.F. Lafferty & Co., Inc.](ex1-1.htm) |
| 5.1 | [Opinion of Winston & Strawn LLP.](ex5-1.htm) |
| 23.1 | [Consent of Winston & Strawn LLP (included in the opinion filed as Exhibit 5.1).](ex5-1.htm) |
| 104 | The cover page from this Current Report on Form 8-K, formatted in Inline XBRL. |

---

**SIGNATURES**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

---

| | | |
|:---|:---|:---|
|  | **Eightco Holdings Inc.** | **Eightco Holdings Inc.** |
| Dated: September 10, 2025 | By: | */s/ Brett Vroman&nbsp;&nbsp;&nbsp;&nbsp;* |
|  | Name: | Brett Vroman |
|  | Title: | Chief Financial Officer |

---

## Exhibit 1.1

**Exhibit 1.1**

**EIGHTCO HOLDINGS INC.**

Shares of Common Stock

(par value $0.001 per share)

**<u>Sales Agreement</u>**

September 10, 2025

R.F. Lafferty & Co., Inc.

40 Wall Street, Suite 3602

New York, NY 10005

Ladies and Gentlemen:

Eightco Holdings Inc., a Delaware corporation (the "**<u>Company</u>**"), confirms its agreement (this "**<u>Agreement</u>**") with R.F. Lafferty & Co., Inc. ("**<u>Lafferty</u>**" or the "**<u>Agent</u>**"), as follows:

1. <u>Issuance and Sale of Placement Shares</u>. The Company agrees that, from time to time during the term
 of this Agreement, on the terms and subject to the conditions set forth herein, it may issue
 and sell to or through Lafferty, as principal and/or the sole designated sales agent,
 shares of common stock (the "  **<u>Placement Shares</u>**") of the Company,
 par value $0.001 per share (the "  **<u>Common Stock</u>** "); *provided*, *however*, that in no event shall the Company issue or sell through the Agent such
 number or dollar amount of Placement Shares that would (a) exceed the number or dollar amount
 of shares of Common Stock registered on the effective Registration Statement (defined below)
 pursuant to which the offering is being made, (b) exceed the number of authorized but unissued
 shares of Common Stock (less shares of Common Stock issuable upon exercise, conversion or
 exchange of any outstanding securities of the Company or otherwise reserved from the Company's
 authorized capital stock), (c) exceed the number or dollar amount of shares of Common Stock
 permitted to be sold under Form S-3 (including General Instruction I.B.6 thereof, if applicable)
 or (d) exceed the number or dollar amount of shares of Common Stock for which the Company
 has filed a Prospectus Supplement (defined below) (the lesser of (a), (b), (c) and (d), the
 "  **<u>Maximum Amount</u>** "). Notwithstanding anything to the contrary contained
 herein, the parties hereto agree that compliance with the limitations set forth in this <u>Section 1</u> on the amount of Placement Shares issued and sold under this Agreement shall be the
 sole responsibility of the Company and that the Agent shall have no obligation in connection
 with such compliance. The offer and sale of Placement Shares through the Agent will be effected
 pursuant to the Registration Statement (defined below) filed by the Company and which will
 be declared or deemed effective by the Securities and Exchange Commission (the "  **<u>Commission</u>** "),
 although nothing in this Agreement shall be construed as requiring the Company to use the
 Registration Statement to issue Common Stock.

The Company will file, in accordance with the provisions of the Securities Act of 1933, as amended (the "**<u>Securities Act</u>**"), and the rules and regulations thereunder (the "**<u>Securities Act Regulations</u>**"), with the Commission a registration statement on Form S-3, including a base prospectus, relating to certain securities, including the Placement Shares to be issued from time to time by the Company, and which incorporates by reference documents that the Company has filed or will file in accordance with the provisions of the Securities Exchange Act of 1934, as amended (the "**<u>Exchange Act</u>**"), and the rules and regulations thereunder. The Company has prepared a prospectus included as part of the registration statement, which prospectus relates to the Placement Shares to be issued from time to time by the Company (the "**<u>Sales Prospectus</u>**"). Except where the context otherwise requires, such registration statement, as amended by any post-effective amendment thereto, including all documents filed as part thereof or incorporated by reference therein, and including any information contained in a Prospectus (defined below) subsequently filed with the Commission pursuant to Rule 424(b) under the Securities Act Regulations or deemed to be a part of such registration statement pursuant to Rule 430B of the Securities Act Regulations, and any one or more additional effective registration statements on Form S-3 from time to time that will contain a base prospectus and related prospectus or prospectus supplement, if applicable (which shall be a "**<u>Prospectus Supplement</u>**"), with respect to the Placement Shares, is herein called the "**<u>Registration Statement</u>**." The base prospectus or base prospectuses (including the Sales Prospectus), including all documents incorporated therein by reference, included in the Registration Statement, as they may be supplemented, if necessary, by a Prospectus Supplement, in the form in which such prospectus or prospectuses and/or Prospectus Supplement have most recently been filed by the Company with the Commission pursuant to Rule 424(b) under the Securities Act Regulations, together with the then issued **Issuer Free Writing Prospectus**(es) (defined below), is herein called the "**<u>Prospectus</u>**."

Any reference herein to the Registration Statement, any Prospectus Supplement, the Prospectus or any Issuer Free Writing Prospectus, and, in each case, any amendments and supplements thereto, shall be deemed to refer to and include the documents, if any, incorporated by reference therein (the "**<u>Incorporated Documents</u>**"), including, unless the context otherwise requires, the documents, if any, filed as exhibits to such Incorporated Documents. Any reference herein to the terms "amend," "amendment" or "supplement" with respect to the Registration Statement, any Prospectus Supplement, the Prospectus or any Issuer Free Writing Prospectus shall be deemed to refer to and include the filing of any document under the Exchange Act on or after the most-recent effective date of the Registration Statement, or the date of the Prospectus Supplement, Prospectus or such Issuer Free Writing Prospectus, as the case may be, and incorporated therein by reference. For purposes of this Agreement, all references to the Registration Statement, the Prospectus or to any amendment or supplement thereto shall be deemed to include the most recent copy filed with the Commission pursuant to its Electronic Data Gathering Analysis and Retrieval system, or if applicable, the Interactive Data Electronic Application system when used by the Commission (collectively, "**<u>EDGAR</u>**").

2. <u>Placements</u>.
 Each time that the Company wishes and determines in its sole discretion to issue and sell Placement Shares hereunder (each, a "  **<u>Placement</u>** "),
 it will notify Lafferty by email notice (or other method mutually agreed to by the parties) of the number of Placement Shares
 to be issued, the time period during which sales are requested to be made, any limitation on the number of Placement Shares that
 may be sold in any one day and any minimum price below which sales may not be made (a "  **<u>Placement Notice</u>** "),
 the form of which is attached hereto as <u>Schedule 1</u>. The Placement Notice shall originate from any of the individuals from
 the Company set forth on <u>Schedule 3</u> (with a copy to each of the other individuals from the Company listed on such schedule),
 and shall be addressed to each of the individuals from Lafferty set forth on <u>Schedule 3</u>, as such <u>Schedule 3</u> may be amended in writing from time to time. The Placement Notice shall be effective unless and until (i) Lafferty declines
 to accept the terms contained therein for any reason, in its sole discretion, (ii) the entire amount of the Placement Shares thereunder
 have been sold, (iii) the Company suspends or terminates the Placement Notice, or (iv) this Agreement has been terminated under the
 provisions of <u>Section 12</u>. The amount of any discount, commission or other compensation to be paid by the Company to Lafferty
 in connection with the sale of the Placement Shares shall be calculated in accordance with the terms set forth in <u>Schedule 2</u>.
 It is expressly acknowledged and agreed that neither the Company nor Lafferty will have any obligation whatsoever with respect
 to a Placement or any Placement Shares unless and until the Company delivers a Placement Notice to Lafferty and Lafferty
 does not decline such Placement Notice pursuant to the terms set forth above, and then only upon the terms specified therein and
 herein. In the event of a conflict between the terms of this Agreement and the terms of a Placement Notice, the terms of the Placement
 Notice will control (unless such Placement Notice is declined, suspended or otherwise terminated in accordance with the terms of
 this Agreement).

3. <u>Sale of Placement Shares by Lafferty</u>. Subject to the provisions of <u>Section 5(a)</u>, Lafferty, for the period
 specified in the Placement Notice, will use its commercially reasonable efforts consistent with its normal trading and sales practices
 and applicable state and federal laws, rules and regulations and the rules of The Nasdaq Capital Market (the "  **<u>Exchange</u>** "),
 to sell the Placement Shares up to the amount specified in, and otherwise in accordance with the terms of, such Placement Notice.
 Lafferty will provide written confirmation to the Company no later than the opening of the Trading Day (defined below) immediately
 following the Trading Day on which it has made sales of Placement Shares hereunder setting forth the number of Placement Shares sold
 on such day, the compensation payable by the Company to Lafferty pursuant to <u>Section 2</u> with respect to such sales,
 and the Net Proceeds (defined below) payable to the Company, with an itemization of the deductions made by Lafferty (as set
 forth in <u>Section 5(b)</u>) from the gross proceeds that it receives from such sales. Subject to the terms of the Placement Notice,
 Lafferty may sell Placement Shares by any method permitted by law deemed to be an "at the market offering" as defined
 in Rule 415(a)(4) of the Securities Act Regulations. "  **<u>Trading Day</u>**" means any day on which the Common Stock
 is traded on the Exchange.

4. <u>Suspension of Sales</u>. The Company or Lafferty may, upon notice to the other party in writing (including by email correspondence to each
 of the individuals of the other party set forth on <u>Schedule 3</u>, if receipt of such correspondence is actually acknowledged
 by any of the individuals to whom the notice is sent, other than via auto-reply) or by telephone (confirmed immediately by verifiable
 facsimile transmission or email correspondence to each of the individuals of the other party set forth on <u>Schedule 3</u>), suspend
 any sale of Placement Shares (a "  **<u>Suspension</u>** "); *provided*, *however*, that such Suspension shall
 not affect or impair any party's obligations with respect to any Placement Shares sold hereunder prior to the receipt of such
 notice. While a Suspension is in effect any obligation under <u>Sections 7(l)</u>, <u>7(m)</u>, and <u>7(n)</u> with respect to the
 delivery of certificates, opinions, or comfort letters to the Agent, shall be waived. Each of the parties agrees that no such notice
 under this <u>Section 4</u> shall be effective against any other party unless it is made to one of the individuals named on <u>Schedule 3</u> hereto, as such Schedule may be amended from time to time. Notwithstanding any other provision of this Agreement, during any
 period in which the Company is in possession of material non-public information, the Company and the Agent agree that (i) no sale
 of Placement Shares will take place, (ii) the Company shall not request the sale of any Placement Shares, and (iii) the Agent shall
 not be obligated to sell or offer to sell any Placement Shares.

5. <u>Sale and Delivery to Lafferty; Settlement</u>.

(a) <u>Sale of Placement Shares</u> *.* On the basis of the representations and warranties herein contained and subject to the terms and
 conditions herein set forth, upon Lafferty's acceptance of the terms of a Placement Notice, and unless the sale of the
 Placement Shares described therein has been declined, suspended, or otherwise terminated in accordance with the terms of this Agreement,
 Lafferty, for the period specified in the Placement Notice, will use its commercially reasonable efforts consistent with its
 normal trading and sales practices and applicable law and regulations to sell such Placement Shares up to the amount specified, and
 otherwise in accordance with the terms of such Placement Notice. The Company acknowledges and agrees that (i) there can be no assurance
 that Lafferty will be successful in selling Placement Shares, (ii) Lafferty will incur no liability or obligation to
 the Company or any other person or entity if it does not sell Placement Shares for any reason other than a failure by Lafferty
 to use its commercially reasonable efforts consistent with its normal trading and sales practices and applicable law and regulations
 to sell such Placement Shares as required under this Agreement and (iii) Lafferty shall be under no obligation to purchase
 Placement Shares on a principal basis pursuant to this Agreement, except as otherwise agreed by Lafferty and the Company.

(b) <u>Settlement of Placement Shares</u> *.* Unless otherwise specified in the applicable Placement Notice, settlement for sales of Placement
 Shares will occur on the first (1st) Trading Day (or such earlier day as is industry practice for regular-way trading) following
 the date on which such sales are made (each, a "  **<u>Settlement Date</u>** "). Lafferty shall notify the Company
 of each sale of Placement Shares no later than the opening of the Trading Day immediately following the Trading Day on which it has
 made sales of Placement Shares hereunder. The amount of proceeds to be delivered to the Company on a Settlement Date against receipt
 of the Placement Shares sold (the "  **<u>Net Proceeds</u>**") will be equal to the aggregate sales price received by
 Lafferty, after deduction for (i) the Lafferty's commission, discount or other compensation for such sales payable
 by the Company pursuant to <u>Section 2</u> hereof, and (ii) any transaction fees imposed by any Governmental Authority (defined
 below) in respect of such sales.

(c) **  <u>Delivery of Placement Shares</u>. On or before each Settlement Date, the Company will, or will cause its transfer agent to, electronically
 transfer the Placement Shares being sold by crediting the Lafferty's or its designee's account (provided Lafferty
 shall have given the Company written notice of such designee at least one Trading Day prior to the Settlement Date) at The Depository
 Trust Company through its Deposit and Withdrawal at Custodian System or by such other means of delivery as may be mutually agreed
 upon by the parties hereto which in all cases shall be freely tradable, transferable, registered shares in good deliverable form.
 On each Settlement Date, Lafferty will deliver the related Net Proceeds in same day funds to an account designated by the
 Company on, or prior to, the Settlement Date. The Company agrees that if the Company, or its transfer agent (if applicable), defaults
 in its obligation to deliver Placement Shares on a Settlement Date, the Company agrees that in addition to and in no way limiting
 the rights and obligations set forth in <u>Section 10(a)</u> hereto, it will (i) hold Lafferty harmless against any loss,
 claim, damage, or expense (including reasonable legal fees and expenses), as incurred, arising out of or in connection with such
 default by the Company or its transfer agent (if applicable) and (ii) pay to Lafferty any commission, discount, or other compensation
 to which it would otherwise have been entitled absent such default.

(d) <u>Denominations; Registration</u> *.* Certificates for the Placement Shares, if any, shall be in such denominations and registered in such names
 as the Agent may request in writing at least one full Business Day (defined below) before the applicable Settlement Date. The certificates
 for the Placement Shares, if any, will be made available by the Company for examination and packaging by the Agent in The City of
 New York not later than noon (New York time) on the Business Day prior to the applicable Settlement Date.

(e) <u>Limitations on Offering Size</u> *.* Under no circumstances shall the Company cause or request the offer or sale of any Placement Shares
 if, after giving effect to the sale of such Placement Shares, the aggregate gross sales proceeds of Placement Shares sold pursuant
 to this Agreement would exceed the lesser of (A) together with all sales of Placement Shares under this Agreement, the Maximum Amount
 and (B) the amount authorized from time to time to be issued and sold under this Agreement by the Company's board of directors,
 a duly authorized committee thereof or a duly authorized executive committee, and notified to Lafferty in writing. Under no
 circumstances shall the Company cause or request the offer or sale of any Placement Shares pursuant to this Agreement at a price
 lower than the minimum price authorized from time to time by the Company's board of directors, a duly authorized committee
 thereof or a duly authorized executive committee. Further, under no circumstances shall the Company cause or permit the aggregate
 offering amount of Placement Shares sold pursuant to this Agreement to exceed the Maximum Amount.

6. <u>Representations and Warranties of the Company</u>. The Company represents and warrants to, and agrees with the Agent that as of the date
 of this Agreement and as of each Applicable Time (defined below):

(a) <u>Registration Statement and Prospectus</u>. The Company and the transactions contemplated by this Agreement meet the requirements for and comply
 with the applicable conditions set forth in Form S-3 (including General Instructions I.A and I.B) under the Securities Act. The Registration
 Statement has been or will be filed with the Commission and has been or will be declared or deemed effective by the Commission under
 the Securities Act prior to the issuance of any Placement Notices by the Company. As of each Applicable Time, the Registration Statement
 is effective. The Sales Prospectus will name the Agent as the agent in the section entitled "Plan of Distribution." The
 Company has not received, and has no notice of, any order of the Commission preventing or suspending the use of the Registration
 Statement, or threatening or instituting proceedings for that purpose. The Registration Statement and the offer and sale of Placement
 Shares as contemplated hereby meet the requirements of Rule 415 under the Securities Act and comply in all material respects with
 said Rule. Any statutes, regulations, contracts or other documents that are required to be described in the Registration Statement
 or the Prospectus or to be filed as exhibits to the Registration Statement have been so described or filed. Copies of the Registration
 Statement, the Prospectus, and any such amendments or supplements and all documents incorporated by reference therein that were filed
 with the Commission on or prior to the date of this Agreement have been delivered, or are available through EDGAR, to the Agent and
 its counsel. The Company has not distributed and, prior to the later to occur of each Settlement Date and completion of the
 distribution of the Placement Shares, will not distribute any offering material in connection with the offering or sale of the Placement
 Shares other than the Registration Statement and the Prospectus and any Issuer Free Writing Prospectus to which the Agent has
 consented. The Common Stock is registered pursuant to Section 12(b) of the Exchange Act and is currently listed on the Exchange under
 the trading symbol "OCTO." The Company has taken no action designed to, or likely to have the effect of, terminating
 the registration of the Common Stock under the Exchange Act, delisting the Common Stock from the Exchange, nor has the Company received
 any notification that the Commission or the Exchange is contemplating terminating such registration or listing. To the Company's
 knowledge, it is in compliance with all applicable listing requirements of the Exchange.

(b) <u>No Misstatement or Omission</u>. The Registration Statement, when it became or becomes effective, and the Prospectus, and any amendment
 or supplement thereto, on the date of such Prospectus or amendment or supplement, conformed and will conform in all material respects
 with the requirements of the Securities Act. At each Settlement Date, the Registration Statement and the Prospectus, as of such date,
 will conform in all material respects with the requirements of the Securities Act. The Registration Statement, when it became or
 becomes effective, did not, and will not, contain an untrue statement of a material fact or omit to state a material fact required
 to be stated therein or necessary to make the statements therein not misleading. The Prospectus and any amendment and supplement
 thereto, on the date thereof and at each Applicable Time (defined below), did not or will not include an untrue statement of a material
 fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances under
 which they were made, not misleading. The documents incorporated by reference in the Prospectus or any Prospectus Supplement did
 not, and any further documents filed and incorporated by reference therein will not, when filed with the Commission, contain an untrue
 statement of a material fact or omit to state a material fact required to be stated in such document or necessary in order to make
 the statements in such document, in the light of the circumstances under which they were made, not misleading. The foregoing shall
 not apply to statements in, or omissions from, any such document made in reliance upon, and in conformity with, information furnished
 to the Company by the Agent in writing specifically for use in the preparation thereof, it being understood and agreed that the only
 such information furnished by the Agent to the Company consists of Agent's Information (as defined below).

(c) <u>Conformity with the Securities Act and Exchange Act</u>. The Registration Statement, the Prospectus, any Issuer Free Writing Prospectus or any
 amendment or supplement thereto, and the documents incorporated by reference in the Registration Statement, the Prospectus or any
 amendment or supplement thereto, when such documents were or are filed with the Commission under the Securities Act or the Exchange
 Act or became or become effective under the Securities Act, as the case may be, conformed or will conform in all material respects
 with the requirements of the Securities Act and the Exchange Act, as applicable.

(d) <u>Financial Information</u>. The consolidated financial statements of the Company included or incorporated by reference in the Registration Statement,
 the Prospectus and the Issuer Free Writing Prospectuses, if any, together with the related notes and schedules, present fairly, in
 all material respects, the consolidated financial position of the Company and the Subsidiaries (defined below) as of the dates indicated
 and the consolidated results of operations, cash flows and changes in stockholders' equity of the Company for the periods specified
 and have been prepared in compliance with the requirements of the Securities Act and Exchange Act and in conformity with U.S. Generally
 Accepted Accounting Principles ("  **<u>GAAP</u>**") applied on a consistent basis during the periods involved; the
 other financial and statistical data with respect to the Company and the Subsidiaries (defined below) contained or incorporated by
 reference in the Registration Statement, the Prospectus and the Issuer Free Writing Prospectuses, if any, are accurately and fairly
 presented and prepared on a basis consistent with the financial statements and books and records of the Company; there are no financial
 statements (historical or pro forma) that are required to be included or incorporated by reference in the Registration Statement,
 or the Prospectus that are not included or incorporated by reference as required; the Company and the Subsidiaries (defined below)
 do not have any material liabilities or obligations, direct or contingent (including any off-balance sheet obligations), not described
 in the Registration Statement (excluding the exhibits thereto), and the Prospectus; and all disclosures contained or incorporated
 by reference in the Registration Statement, the Prospectus and the Issuer Free Writing Prospectuses, if any, regarding "non-GAAP
 financial measures" (as such term is defined by the rules and regulations of the Commission) comply with Regulation G of the
 Exchange Act and Item 10 of Regulation S-K under the Securities Act, to the extent applicable. The interactive data in eXtensible
 Business Reporting Language included or incorporated by reference in the Registration Statement and the Prospectus fairly presents
 the information called for in all material respects and has been prepared in accordance with the Commission's rules and guidelines
 applicable thereto.

(e) <u>Conformity with EDGAR Filing</u>. The Prospectus delivered to the Agent for use in connection with the sale of the Placement Shares pursuant
 to this Agreement will be identical to the versions of the Prospectus created to be transmitted to the Commission for filing via
 EDGAR, except to the extent permitted by Regulation S-T.

(f) <u>Organization</u>.
 The Company and each of its Subsidiaries are duly organized, validly existing as a corporation or other business entity, as applicable,
 and in good standing under the laws of their respective jurisdictions of organization. The Company and each of its Subsidiaries are
 duly licensed or qualified as a foreign corporation for transaction of business and in good standing under the laws of each other
 jurisdiction in which their respective ownership or lease of property or the conduct of their respective businesses requires such
 license or qualification, and have all corporate power and authority necessary to own or hold their respective properties and to
 conduct their respective businesses as described in the Registration Statement and the Prospectus, except where the failure to be
 so qualified or in good standing or have such power or authority would not, individually or in the aggregate, have a material adverse
 effect or would reasonably be expected to have a material adverse effect on or affecting the assets, business, operations, earnings,
 properties, condition (financial or otherwise), prospects, stockholders' equity or results of operations of the Company and
 the Subsidiaries taken as a whole, or prevent or materially interfere with consummation of the transactions contemplated hereby (a
 "  **<u>Material Adverse Effect</u>** ").

(g) <u>Subsidiaries</u>.
 The subsidiaries set forth on <u>Schedule 4</u> (collectively, the "  **<u>Subsidiaries</u>** "), are the Company's
 only significant subsidiaries (as such term is defined in Rule 1-02 of Regulation S-X promulgated by the Commission). Except as set
 forth in the Registration Statement and in the Prospectus, the Company owns, directly or indirectly, all of the equity interests
 of the Subsidiaries free and clear of any lien, charge, security interest, encumbrance, right of first refusal or other restriction,
 and all the equity interests of the Subsidiaries are validly issued and are fully paid, nonassessable and free of preemptive and
 similar rights. No Subsidiary is currently prohibited, directly or indirectly, from paying any dividends to the Company, from making
 any other distribution on such Subsidiary's capital stock, from repaying to the Company any loans or advances to such Subsidiary
 from the Company or from transferring any of such Subsidiary's property or assets to the Company or any other Subsidiary of
 the Company.

(h) <u>No Violation or Default</u>. Neither the Company nor any of its Subsidiaries is (i) in violation of its charter or by-laws or similar
 organizational documents; (ii) in default, and no event has occurred that, with notice or lapse of time or both, would constitute
 such a default, in the due performance or observance of any term, covenant or condition contained in any indenture, mortgage, deed
 of trust, loan or credit agreement or other agreement or instrument to which the Company or any of its Subsidiaries is a party or
 by which the Company or any of its Subsidiaries is bound or to which any of the property or assets of the Company or any of its Subsidiaries
 are subject; or (iii) in violation of any law or statute or any judgment, order, rule or regulation of any Governmental Authority,
 except, in the case of each of clauses (ii) and (iii) above, for any such violation or default that would not, individually or in
 the aggregate, have a Material Adverse Effect. To the Company's knowledge, no other party under any material contract or other
 agreement to which it or any of its Subsidiaries is a party is in default in any respect thereunder where such default would have
 a Material Adverse Effect.

(i) <u>No Material Adverse Change</u>. Subsequent to the respective dates as of which information is given in the Registration Statement, the
 Prospectus and the Issuer Free Writing Prospectuses, if any (including any document deemed incorporated by reference therein), there
 has not been (i) any Material Adverse Effect or the occurrence of any development that the Company reasonably expects will result
 in a Material Adverse Effect, (ii) any transaction which is material to the Company and the Subsidiaries taken as a whole, (iii)
 any obligation or liability, direct or contingent (including any off-balance sheet obligations), incurred by the Company or any Subsidiary,
 which is material to the Company and the Subsidiaries taken as a whole, (iv) any material change in the capital stock or outstanding
 long-term indebtedness of the Company or any of its Subsidiaries or (v) any dividend or distribution of any kind declared, paid or
 made on the capital stock of the Company or any Subsidiary, other than in each case above in the ordinary course of business or as
 otherwise disclosed in the Registration Statement or the Prospectus (including any document deemed incorporated by reference therein).

(j) <u>Capitalization</u>.
 The issued and outstanding shares of capital stock of the Company have been validly issued, are fully paid and nonassessable and,
 other than as disclosed in the Registration Statement or the Prospectus, are not subject to any preemptive rights, rights of first
 refusal or similar rights. The Company has an authorized, issued and outstanding capitalization as set forth in the Registration
 Statement and the Prospectus as of the dates referred to therein (other than the grant of additional options under the Company's
 existing stock option plans, or changes in the number of outstanding shares of Common Stock of the Company due to the issuance of
 shares upon the exercise or conversion of securities exercisable for, or convertible into, Common Stock outstanding on the date hereof)
 and such authorized capital stock conforms to the description thereof set forth in the Registration Statement and the Prospectus.
 The description of the securities of the Company in the Registration Statement and the Prospectus is complete and accurate in all
 material respects. Except as disclosed in or contemplated by the Registration Statement or the Prospectus, as of the date referred
 to therein, the Company does not have outstanding any options to purchase, or any rights or warrants to subscribe for, or any securities
 or obligations convertible into, or exchangeable for, or any contracts or commitments to issue or sell, any shares of capital stock
 or other securities.

(k) <u>Authorization; Enforceability</u>. The Company has full legal right, power and authority to enter into this Agreement and perform the transactions
 contemplated hereby. This Agreement has been duly authorized, executed and delivered by the Company and is a legal, valid and binding
 agreement of the Company enforceable in accordance with its terms, except to the extent that enforceability may be limited by bankruptcy,
 insolvency, reorganization, moratorium or similar laws affecting creditors' rights generally and by general equitable principles.

(l) <u>Authorization of Placement Shares</u>. The Placement Shares, when issued and delivered pursuant to the terms approved by the board of directors
 of the Company or a duly authorized committee thereof, or a duly authorized executive committee, against payment therefor as provided
 herein, will be duly and validly authorized and issued and fully paid and nonassessable, free and clear of any pledge, lien, encumbrance,
 security interest or other claim, including any statutory or contractual preemptive rights, resale rights, rights of first refusal
 or other similar rights, and will be registered pursuant to Section 12 of the Exchange Act. The Placement Shares, when issued, will
 conform to the description thereof set forth in or incorporated into the Prospectus.

(m) <u>No Consents Required</u>. No consent, approval, authorization, order, registration or qualification of or with any Governmental Authority
 is required for the execution, delivery and performance by the Company of this Agreement, the issuance and sale by the Company of
 the Placement Shares, except for such consents, approvals, authorizations, orders and registrations or qualifications as may be required
 under applicable state securities laws or by the by-laws and rules of the Financial Industry Regulatory Authority ("  **<u>FINRA</u>** ")
 or the Exchange in connection with the sale of the Placement Shares by the Agent.

(n) <u>No Preferential Rights</u>. Except as set forth in the Registration Statement and the Prospectus, (i) no person, as such term is defined
 in Rule 1-02 of Regulation S-X promulgated under the Securities Act (each, a "  **<u>Person</u>** "), has the right,
 contractual or otherwise, to cause the Company to issue or sell to such Person any Common Stock or shares of any other capital stock
 or other securities of the Company, (ii) no Person has any preemptive rights, resale rights, rights of first refusal, rights of co-sale,
 or any other rights (whether pursuant to a "poison pill" provision or otherwise) to purchase any Common Stock or shares
 of any other capital stock or other securities of the Company, (iii) no Person has the right to act as an underwriter or as a financial
 advisor to the Company in connection with the offer and sale of the Common Stock, and (iv) no Person has the right, contractual or
 otherwise, to require the Company to register under the Securities Act any Common Stock or shares of any other capital stock or other
 securities of the Company, or to include any such shares or other securities in the Registration Statement or the offering contemplated
 thereby, whether as a result of the filing or effectiveness of the Registration Statement or the sale of the Placement Shares as
 contemplated thereby or otherwise.

(o) <u>Independent Public Accounting Firm</u>. Stephano Slack LLC (the "  **<u>Accountant</u>** "), whose report on the consolidated financial
 statements of the Company is filed with the Commission as part of the Company's most recent Annual Report on Form 10-K filed
 with the Commission and incorporated by reference into the Registration Statement and the Prospectus, are and, during the periods
 covered by their report, were an independent registered public accounting firm within the meaning of the Securities Act and the Public
 Company Accounting Oversight Board (United States) ("  **<u>PCAOB</u>** "). To the Company's knowledge, the Accountant
 is not in violation of the auditor independence requirements of the Sarbanes-Oxley Act of 2002 (the "  **<u>Sarbanes-Oxley Act</u>** ")
 with respect to the Company.

(p) <u>Enforceability of Agreements</u>. All agreements between the Company and third parties expressly referenced in the Prospectus are legal, valid and
 binding obligations of the Company enforceable in accordance with their respective terms, except to the extent that (i) enforceability
 may be limited by bankruptcy, insolvency, reorganization, moratorium or similar laws affecting creditors' rights generally
 and by general equitable principles and (ii) the indemnification provisions of certain agreements may be limited by federal or state
 securities laws or public policy considerations in respect thereof.

(q) <u>No Litigation</u>. Except as set forth in the Registration Statement or the Prospectus, there are no actions, suits or proceedings by
 or before any Governmental Authority pending, nor, to the Company's knowledge, any audits or investigations by or before any
 Governmental Authority to which the Company or a Subsidiary is a party or to which any property of the Company or any of its Subsidiaries
 is the subject that, individually or in the aggregate, would have a Material Adverse Effect and, to the Company's knowledge,
 no such actions, suits, proceedings, audits or investigations are threatened or contemplated by any Governmental Authority or threatened
 by others; and (i) there are no current or pending audits or investigations, actions, suits or proceedings by or before any Governmental
 Authority that are required under the Securities Act to be described in the Prospectus that are not so described; and (ii) there
 are no contracts or other documents that are required under the Securities Act to be filed as exhibits to the Registration Statement
 that are not so filed.

(r) <u>Consents and Permits</u>. The Company and each Subsidiary possess such valid and current certificates, authorizations or permits issued by
 the appropriate state, federal or foreign regulatory agencies or bodies necessary to conduct their respective businesses, and neither
 the Company nor any Subsidiary has received, or has any reason to believe that it will receive, any notice of proceedings relating
 to the revocation or modification of, or non-compliance with, any such certificate, authorization or permit which, singly or in the
 aggregate, if the subject of an unfavorable decision, ruling or finding, could result in a Material Adverse Effect.

(s) <u>[Reserved]</u>.

(t) <u>Intellectual Property</u>. Except as disclosed in the Registration Statement and the Prospectus, the Company and its Subsidiaries own, possess,
 license or have other rights to use all foreign and domestic patents, patent applications, trade and service marks, trade and service
 mark registrations, trade names, copyrights, licenses, inventions, trade secrets, technology, Internet domain names, know-how and
 other intellectual property (collectively, the "  **<u>Intellectual Property</u>** "), necessary for the conduct of their
 respective businesses as now conducted except to the extent that the failure to own, possess, license or otherwise hold adequate
 rights to use such Intellectual Property would not, individually or in the aggregate, have a Material Adverse Effect. Except as disclosed
 in the Registration Statement and the Prospectus (i) there are no rights of third parties to any such Intellectual Property owned
 by the Company and its Subsidiaries; (ii) to the Company's knowledge, there is no infringement by third parties of any such
 Intellectual Property; (iii) there is no pending or, to the Company's knowledge, threatened action, suit, proceeding or claim
 by others challenging the Company's and its Subsidiaries' rights in or to any such Intellectual Property, and the Company
 is unaware of any facts which could form a reasonable basis for any such action, suit, proceeding or claim; (iv) there is no pending
 or, to the Company's knowledge, threatened action, suit, proceeding or claim by others challenging the validity or scope of
 any such Intellectual Property; (v) there is no pending or, to the Company's knowledge, threatened action, suit, proceeding
 or claim by others that the Company and its Subsidiaries infringe or otherwise violate any patent, trademark, copyright, trade secret
 or other proprietary rights of others; (vi) to the Company's knowledge, there is no third-party U.S. patent or published U.S.
 patent application which contains claims for which an Interference Proceeding (as defined in 35 U.S.C. § 135) has been commenced
 against any patent or patent application described in the Prospectus as being owned by or licensed to the Company; and (vii) the
 Company and its Subsidiaries have complied with the terms of each agreement pursuant to which Intellectual Property has been licensed
 to the Company or such Subsidiary, and all such agreements are in full force and effect, except, in the case of any of clauses (i)-(vii)
 above, for any such infringement by third parties or any such pending or threatened suit, action, proceeding or claim as would not,
 individually or in the aggregate, result in a Material Adverse Effect.

(u) <u>[Reserved]</u>.

(v) <u>Market Capitalization</u>. At the time the Registration Statement was or will be originally declared effective, and at the time the Company's
 most recent Annual Report on Form 10-K was filed with the Commission, the Company met or will meet the then applicable requirements
 for the use of Form S-3 under the Securities Act, including, but not limited to, General Instruction I.B.1 of Form S-3. The Company
 is not a shell company (as defined in Rule 405 under the Securities Act) and has not been a shell company for at least 12 calendar
 months previously and if it has been a shell company at any time previously, has filed current Form 10 information (as defined in
 Instruction I.B.6 of Form S-3) with the Commission at least 12 calendar months previously reflecting its status as an entity that
 is not a shell company.

(w) <u>FINRA Matters</u>. The information provided to the Agent by the Company, its counsel, and its officers and directors for purposes of the
 Agent's compliance with applicable FINRA rules in connection with the offering of the Shares is true, complete, and
 correct and compliant with FINRA's rules.

(x) <u>No Material Defaults</u>. Neither the Company nor any of the Subsidiaries has defaulted on any installment on indebtedness for borrowed
 money or on any rental on one or more long-term leases, which defaults, individually or in the aggregate, would have a Material Adverse
 Effect. The Company has not filed a report pursuant to Section 13(a) or 15(d) of the Exchange Act since the filing of its last Annual
 Report on Form 10-K, indicating that it (i) has failed to pay any dividend or sinking fund installment on preferred stock or (ii)
 has defaulted on any installment on indebtedness for borrowed money or on any rental on one or more long-term leases, which defaults,
 individually or in the aggregate, would have a Material Adverse Effect.

(y) <u>Certain Market Activities</u>. Neither the Company, nor any of the Subsidiaries, nor any of their respective directors, officers or controlling
 persons has taken, directly or indirectly, any action designed, or that has constituted or would reasonably be expected to cause
 or result in, under the Exchange Act or otherwise, the stabilization or manipulation of the price of (i) Worldcoin ("  **<u>WLD</u>** ")
 or (ii) any security of the Company to facilitate the sale or resale of the Placement Shares. Further, to the best of the Company's
 knowledge, neither the Company nor MOZAYYX, or any of their respective affiliates, has taken any action designed, or that has constituted
 or would reasonably be expected to cause and result in, stabilization or manipulation of the price of WLD.

(z) <u>Broker/Dealer Relationships</u>. Neither the Company nor any of the Subsidiaries (i) is required to register as a "broker" or "dealer"
 in accordance with the provisions of the Exchange Act or (ii) directly or indirectly through one or more intermediaries, controls
 or is a "person associated with a member" or "associated person of a member" (within the meaning set forth
 in the FINRA Manual).

(aa) <u>No Reliance</u>. The Company has not relied upon the Agent or legal counsel for the Agent for any legal, tax or accounting advice
 in connection with the offering and sale of the Placement Shares.

(bb) <u>Taxes</u>.
 The Company and each of its Subsidiaries have filed all federal, state, local and foreign tax returns which have been required to
 be filed and paid all taxes shown thereon through the date hereof, to the extent that such taxes have become due and are not being
 contested in good faith, except where the failure to so file or pay would not have a Material Adverse Effect. Except as otherwise
 disclosed in or contemplated by the Registration Statement or the Prospectus, no tax deficiency has been determined adversely to
 the Company or any of its Subsidiaries which has had, or would have, individually or in the aggregate, a Material Adverse Effect.
 The Company has no knowledge of any federal, state or other governmental tax deficiency, penalty or assessment which has been or
 might be asserted or threatened against it which would have a Material Adverse Effect.

(cc) <u>Title to Real and Personal Property</u>. Except as set forth in the Registration Statement or the Prospectus, the Company and its Subsidiaries
 have good and marketable title in fee simple to all items of real property owned by them, good and valid title to all personal property
 described in the Registration Statement or the Prospectus as being owned by them, in each case free and clear of all liens, encumbrances
 and claims, except those matters that (i) do not materially interfere with the use made and proposed to be made of such property
 by the Company and any of its Subsidiaries or (ii) would not, individually or in the aggregate, have a Material Adverse Effect. Any
 real or personal property described in the Registration Statement or the Prospectus as being leased by the Company and any of its
 Subsidiaries is held by them under valid, existing and enforceable leases, except those that (A) do not materially interfere with
 the use made or proposed to be made of such property by the Company or any of its Subsidiaries or (B) would not be reasonably expected,
 individually or in the aggregate, to have a Material Adverse Effect. Each of the properties of the Company and its Subsidiaries complies
 with all applicable codes, laws and regulations (including, without limitation, building and zoning codes, laws and regulations and
 laws relating to access to such properties), except if and to the extent disclosed in the Registration Statement or the Prospectus
 or except for such failures to comply that would not, individually or in the aggregate, reasonably be expected to interfere in any
 material respect with the use made and proposed to be made of such property by the Company and its Subsidiaries or otherwise have
 a Material Adverse Effect. None of the Company or its subsidiaries has received from any Governmental Authorities any notice of any
 condemnation of, or zoning change affecting, the properties of the Company and its Subsidiaries, and the Company knows of no such
 condemnation or zoning change which is threatened, except for such that would not reasonably be expected to interfere in any material
 respect with the use made and proposed to be made of such property by the Company and its Subsidiaries or otherwise have a Material
 Adverse Effect, individually or in the aggregate.

(dd) <u>Environmental Laws</u>. Except as set forth in the Registration Statement or the Prospectus, the Company and its Subsidiaries (i) are in compliance
 with any and all applicable federal, state, local and foreign laws, rules, regulations, decisions and orders relating to the protection
 of human health and safety, the environment or hazardous or toxic substances or wastes, pollutants or contaminants (collectively,
 "  **<u>Environmental Laws</u>** "); (ii) have received and are in compliance with all permits, licenses or other approvals
 required of them under applicable Environmental Laws to conduct their respective businesses as described in the Registration Statement
 and the Prospectus; and (iii) have not received notice of any actual or potential liability for the investigation or remediation
 of any disposal or release of hazardous or toxic substances or wastes, pollutants or contaminants, except, in the case of any of
 clauses (i), (ii) or (iii) above, for any such failure to comply or failure to receive required permits, licenses, other approvals
 or liability as would not, individually or in the aggregate, have a Material Adverse Effect.

(ee) <u>Disclosure Controls</u>. The Company and each of its Subsidiaries maintain systems of internal accounting controls sufficient to provide reasonable
 assurance that (i) transactions are executed in accordance with management's general or specific authorizations; (ii) transactions
 are recorded as necessary to permit preparation of financial statements in conformity with GAAP and to maintain asset accountability;
 (iii) access to assets is permitted only in accordance with management's general or specific authorization; and (iv) the recorded
 accountability for assets is compared with the existing assets at reasonable intervals and appropriate action is taken with respect
 to any differences. The Company's internal control over financial reporting is effective and the Company is not aware of any
 material weaknesses in its internal control over financial reporting (other than as set forth in the Prospectus). Since the date
 of the latest audited financial statements of the Company included in the Prospectus, there has been no change in the Company's
 internal control over financial reporting that has materially affected, or is reasonably likely to materially affect, the Company's
 internal control over financial reporting (other than as set forth in the Prospectus). The Company has established disclosure controls
 and procedures (as defined in Exchange Act Rules 13a-15 and 15d-15) for the Company and designed such disclosure controls and procedures
 to ensure that material information relating to the Company and each of its Subsidiaries is made known to the certifying officers
 by others within those entities, particularly during the period in which the Company's Annual Report on Form 10-K or Quarterly
 Report on Form 10-Q, as the case may be, is being prepared. The Company's certifying officers have evaluated the effectiveness
 of the Company's disclosure controls and procedures as of a date within 90 days prior to the filing date of the Annual Report
 on Form 10-K for the fiscal year most recently ended (such date, the **" <u>Evaluation Date</u>** "). The Company presented
 in its Annual Report on Form 10-K for the fiscal year most recently ended the conclusions of the certifying officers about the effectiveness
 of the disclosure controls and procedures based on their evaluations as of the Evaluation Date and the disclosure controls and procedures
 are effective. Since the Evaluation Date, there have been no significant changes in the Company's internal controls (as such
 term is defined in Item 307(b) of Regulation S-K under the Securities Act) or, to the Company's knowledge, in other factors
 that could significantly affect the Company's internal controls.

(ff) <u>Sarbanes-Oxley</u>.
 There is and has been no failure on the part of the Company or any of the Company's directors or officers, in their capacities
 as such, to comply in all material respects with any applicable provisions of the Sarbanes-Oxley Act and the rules and regulations
 promulgated thereunder. Each of the principal executive officer and the principal financial officer of the Company (or each former
 principal executive officer of the Company and each former principal financial officer of the Company as applicable) has made all
 certifications required by Sections 302 and 906 of the Sarbanes-Oxley Act with respect to all reports, schedules, forms, statements
 and other documents required to be filed by it or furnished by it to the Commission. For purposes of the preceding sentence, "principal
 executive officer" and "principal financial officer" shall have the meanings given to such terms in the Sarbanes-Oxley
 Act.

(gg) <u>Finder's Fees</u>. Neither the Company nor any of the Subsidiaries has incurred any liability for any finder's fees, brokerage commissions
 or similar payments in connection with the transactions herein contemplated, except as may otherwise exist with respect to the Agent
 pursuant to this Agreement.

(hh) <u>Labor Disputes</u>. No labor disturbance by or dispute with employees of the Company or any of its Subsidiaries exists or, to the knowledge
 of the Company, is threatened which would result in a Material Adverse Effect.

(ii) <u>Investment Company Act</u>. Neither the Company nor any of the Subsidiaries is or, after giving effect to the offering and sale of the Placement
 Shares and the application of the Net Proceeds, will be an "investment company" or an entity "controlled"
 by an "investment company," as such terms are defined in the Investment Company Act of 1940, as amended (the "  **<u>Investment Company Act</u>** "). The Company shall conduct its business in a manner so that it will not become an "investment company"
 subject to registration under the Investment Company Act.

(jj) <u>Operations</u>.
 The operations of the Company and its Subsidiaries are and have been conducted at all times in compliance with applicable financial
 record keeping and reporting requirements of the Currency and Foreign Transactions Reporting Act of 1970, as amended, the money laundering
 statutes of all jurisdictions to which the Company or its Subsidiaries are subject, the rules and regulations thereunder and any
 related or similar rules, regulations or guidelines, issued, administered or enforced by any Governmental Authority (collectively,
 the "  **<u>Money Laundering Laws</u>** "); and no action, suit or proceeding by or before any Governmental Authority
 involving the Company or any of its Subsidiaries with respect to the Money Laundering Laws is pending or, to the knowledge of the
 Company, threatened.

(kk) <u>Off-Balance Sheet Arrangements</u>. There are no transactions, arrangements and other relationships between and/or among the Company, and/or
 any of its affiliates and any unconsolidated entity, including, but not limited to, any structured finance, special purpose or limited
 purpose entity (each, an "  **<u>Off-Balance Sheet Transaction</u>**") that could reasonably be expected to affect materially
 the Company's liquidity or the availability of or requirements for its capital resources, including those Off-Balance Sheet
 Transactions described in the Commission's Statement about Management's Discussion and Analysis of Financial Conditions
 and Results of Operations (Release Nos. 33-8056; 34-45321; FR-61), required to be described in the Prospectus which have not been
 described as required.

(ll) <u>Underwriter Agreements</u>. The Company is not a party to any agreement with an agent or underwriter for any other "at the market"
 or continuous equity transaction.

(mm) <u>ERISA</u>.
 To the knowledge of the Company, each material employee benefit plan, within the meaning of Section 3(3) of the Employee Retirement
 Income Security Act of 1974, as amended ("  **<u>ERISA</u>** "), that is maintained, administered or contributed to by
 the Company or any of its affiliates for employees or former employees of the Company and any of its Subsidiaries has been maintained
 in material compliance with its terms and the requirements of any applicable statutes, orders, rules and regulations, including but
 not limited to ERISA and the Internal Revenue Code of 1986, as amended (the "  **<u>Code</u>** "); no prohibited transaction,
 within the meaning of Section 406 of ERISA or Section 4975 of the Code, has occurred which would result in a material liability to
 the Company with respect to any such plan excluding transactions effected pursuant to a statutory or administrative exemption; and
 for each such plan that is subject to the funding rules of Section 412 of the Code or Section 302 of ERISA, no "accumulated
 funding deficiency" as defined in Section 412 of the Code has been incurred, whether or not waived, and the fair market value
 of the assets of each such plan (excluding for these purposes accrued but unpaid contributions) exceeds the present value of all
 benefits accrued under such plan determined using reasonable actuarial assumptions.

(nn) <u>Forward-Looking Statements</u>. No forward-looking statement (within the meaning of Section 27A of the Securities Act and Section 21E of the Exchange
 Act) (a "  **<u>Forward-Looking Statement</u>**") contained in the Registration Statement and the Prospectus has been
 made or reaffirmed without a reasonable basis or has been disclosed other than in good faith.

(oo) <u>Agent Purchases</u>. The Company acknowledges and agrees that the Agent has informed the Company that the Agent may, to the
 extent permitted under the Securities Act and the Exchange Act, purchase and sell Common Stock for its own account while this Agreement
 is in effect, *provided*, that the Company shall not be deemed to have authorized or consented to any such purchases or sales
 by the Agent.

(pp) <u>Margin Rules</u>. Neither the issuance, sale and delivery of the Placement Shares nor the application of the proceeds thereof by the Company
 as described in the Registration Statement and the Prospectus will violate Regulation T, U or X of the Board of Governors of the
 Federal Reserve System or any other regulation of such Board of Governors.

(qq) <u>Insurance</u>.
 The Company and each of its Subsidiaries carry, or are covered by, insurance in such amounts and covering such risks as the Company
 and each of its Subsidiaries reasonably believe are adequate for the conduct of their properties and as is customary for companies
 engaged in similar businesses in similar industries.

(rr) <u>No Improper Practices</u>. (i) Neither the Company nor the Subsidiaries, nor any director, officer, or employee of the Company or any
 Subsidiary nor, to the Company's knowledge, any agent, affiliate or other person acting on behalf of the Company or any Subsidiary
 has, in the past five years, made any unlawful contributions to any candidate for any political office (or failed fully to disclose
 any contribution in violation of applicable law) or made any contribution or other payment to any official of, or candidate for,
 any federal, state, municipal, or foreign office or other person charged with similar public or quasi-public duty in violation of
 any applicable law or of the character required to be disclosed in the Prospectus; (ii) no relationship, direct or indirect, exists
 between or among the Company or any Subsidiary or any affiliate of any of them, on the one hand, and the directors, officers and
 stockholders of the Company or any Subsidiary, on the other hand, that is required by the Securities Act to be described in the Registration
 Statement and the Prospectus that is not so described; (iii) no relationship, direct or indirect, exists between or among the Company
 or any Subsidiary or any affiliate of them, on the one hand, and the directors, officers, or stockholders of the Company or any Subsidiary,
 on the other hand, that is required by the rules of FINRA to be described in the Registration Statement and the Prospectus that is
 not so described; (iv) except as described in the Registration Statement and the Prospectus, there are no material outstanding loans
 or advances or material guarantees of indebtedness by the Company or any Subsidiary to or for the benefit of any of their respective
 officers or directors or any of the members of the families of any of them; and (v) the Company has not offered, or caused any placement
 agent to offer, Common Stock to any person with the intent to influence unlawfully (A) a customer or supplier of the Company or any
 Subsidiary to alter the customer's or supplier's level or type of business with the Company or any Subsidiary or (B)
 a trade journalist or publication to write or publish favorable information about the Company or any Subsidiary or any of their respective
 products or services, and, (vi) neither the Company nor any Subsidiary nor any director, officer or employee of the Company or any
 Subsidiary nor, to the Company's knowledge, any agent, affiliate or other person acting on behalf of the Company or any Subsidiary
 has (A) violated or is in violation of any applicable provision of the U.S. Foreign Corrupt Practices Act of 1977, as amended, or
 any other applicable anti-bribery or anti-corruption law (collectively, "  **<u>Anti-Corruption Laws</u>** "), (B) promised,
 offered, provided, attempted to provide or authorized the provision of anything of value, directly or indirectly, to any person for
 the purpose of obtaining or retaining business, influencing any act or decision of the recipient, or securing any improper advantage;
 or (C) made any payment of funds of the Company or any Subsidiary or received or retained any funds in violation of any Anti-Corruption
 Laws.

(ss) <u>Status Under the Securities Act</u>. The Company was not and is not an ineligible issuer as defined in Rule 405 under the Securities Act
 at the times specified in Rules 164 and 433 under the Securities Act in connection with the offering of the Placement Shares.

(tt) <u>No Misstatement or Omission in an Issuer Free Writing Prospectus</u>. Each Issuer Free Writing Prospectus, as of its issue date and
 as of each Applicable Time (as defined in <u>Section 23</u> below), did not, does not and will not include any information that conflicted,
 conflicts or will conflict with the information contained in the Registration Statement or the Prospectus, including any incorporated
 document deemed to be a part thereof that has not been superseded or modified. The foregoing sentence does not apply to statements
 in or omissions from any Issuer Free Writing Prospectus based upon and in conformity with written information furnished to the Company
 by the Agent specifically for use therein.

(uu) <u>No Conflicts</u>. Neither the execution of this Agreement, nor the issuance, offering or sale of the Placement Shares, nor the consummation
 of any of the transactions contemplated herein and therein, nor the compliance by the Company with the terms and provisions hereof
 and thereof will conflict with, or will result in a breach of, any of the terms and provisions of, or has constituted or will constitute
 a default under, or has resulted in or will result in the creation or imposition of any lien, charge or encumbrance upon any property
 or assets of the Company pursuant to the terms of any contract or other agreement to which the Company may be bound or to which any
 of the property or assets of the Company is subject, except (i) such conflicts, breaches or defaults as may have been waived and
 (ii) such conflicts, breaches and defaults that would not have a Material Adverse Effect; nor will such action result (x) in any
 violation of the provisions of the organizational or governing documents of the Company, or (y) in any material violation of the
 provisions of any statute or any order, rule or regulation applicable to the Company or of any Governmental Authority having jurisdiction
 over the Company.

(vv) <u>Sanctions</u>.
 (i) The Entity represents that, neither the Company nor any of its Subsidiaries (collectively, the "  **<u>Entity</u>** ")
 or any director, officer, employee, agent, affiliate or representative of the Company, is a government, individual, or entity (in
 this paragraph (vv), "  **<u>Person</u>**") that is, or is owned or controlled by a Person that is:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(A) the subject of any sanctions administered or enforced by the U.S. Department of the Treasury's Office of Foreign Assets Control ("**<u>OFAC</u>**"), the United Nations Security Council, the European Union, His Majesty's Treasury, or other relevant sanctions authorities, including, without limitation, designation on OFAC's Specially Designated Nationals and Blocked Persons List or OFAC's Foreign Sanctions Evaders List (as amended, collectively, "**<u>Sanctions</u>**"), nor

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(B) located, organized or resident in a country or territory that is the subject of Sanctions that broadly prohibit dealings with that country or territory (including, without limitation, Cuba, Iran, North Korea, Syria, the so-called Donetsk People's Republic, the so-called Luhansk People's Republic and the Crimea Region of the Ukraine) (the "**Sanctioned Countries**").

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) The Company represents and covenants that the Entity will not, directly or indirectly, use the proceeds of the offering, or lend, contribute or otherwise make available such proceeds to any subsidiary, joint venture partner or other Person:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(A) to fund or facilitate any activities or business of or with any Person or in any country or territory that, at the time of such funding or facilitation, is the subject of Sanctions or is a Sanctioned Country; or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(B) in any other manner that will result in a violation of Sanctions by any Person (including any Person participating in the offering, whether as underwriter, advisor, investor or otherwise).

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii) The Company represents and covenants that, except as detailed in the Registration Statement and the Prospectus, since April 24, 2019, the Entity has not engaged in, is not now engaging in, and will not engage in, any dealings or transactions with any Person, or in any country or territory, that at the time of the dealing or transaction is or was the subject of Sanctions or is or was a Sanctioned Country.

(ww) <u>Stock Transfer Taxes</u>. On each Settlement Date, all stock transfer or other taxes (other than income taxes) which are required to be
 paid in connection with the sale and transfer of the Placement Shares to be sold hereunder will be, or will have been, fully paid
 or provided for by the Company and all laws imposing such taxes will be or will have been fully complied with.

(xx) <u>Compliance with Laws</u>. The Company and each of its Subsidiaries are in compliance with all applicable laws, regulations and statutes (including
 all Environmental Laws and regulations) in the jurisdictions in which it carries on business; the Company has not received a notice
 of non-compliance, nor knows of, nor has reasonable grounds to know of, any facts that could give rise to a notice of non-compliance
 with any such laws, regulations and statutes, and is not aware of any pending change or contemplated change to any such applicable
 law or regulation or governmental position; in each case that would have a Material Adverse Effect on the business of the Company
 or the business or legal environment under which the Company operates.

(yy) <u>Statistical and Market-Related Data</u>. The statistical, demographic and market-related data included in the Registration Statement and Prospectus
 are based on or derived from sources that the Company believes to be reliable and accurate or represent the Company's good
 faith estimates that are made on the basis of data derived from such sources.

(zz) <u>Cybersecurity</u>.
 The Company and its subsidiaries' information technology assets and equipment, computers, systems, networks, hardware, software,
 websites, applications, and databases (collectively, "  **<u>IT Systems</u>**") are adequate for, and operate and perform
 in all material respects as required in connection with the operation of the business of the Company as currently conducted, free
 and clear of all material bugs, errors, defects, Trojan horses, time bombs, malware and other corruptants. The Company and its subsidiaries
 have implemented and maintained commercially reasonable physical, technical and administrative controls, policies, procedures, and
 safeguards to maintain and protect their material confidential information and the integrity, continuous operation, redundancy and
 security of all IT Systems and data, including all "Personal Data" (defined below) and all sensitive, confidential or
 regulated data ("  **<u>Confidential Data</u>**") used in connection with their businesses. "Personal Data"
 means (i) a natural person's name, street address, telephone number, e-mail address, photograph, social security number or
 tax identification number, driver's license number, passport number, credit card number, bank information, or customer or account
 number; (ii) any information which would qualify as "personally identifying information" under the Federal Trade Commission
 Act, as amended; (iii) "personal data" as defined by the European Union General Data Protection Regulation ("  **<u>GDPR</u>** ")
 (EU 2016/679); (iv) any information which would qualify as "protected health information" under the Health Insurance
 Portability and Accountability Act of 1996, as amended by the Health Information Technology for Economic and Clinical Health Act
 (collectively, "  **<u>HIPAA</u>** "); (v) any "personal information" as defined by the California Consumer
 Privacy Act ("  **<u>CCPA</u>** "); and (vi) any other piece of information that allows the identification of such natural
 person, or his or her family, or permits the collection or analysis of any data related to an identified person's health or
 sexual orientation. There have been no breaches, violations, outages or unauthorized uses of or accesses to same, except for those
 that have been remedied without material cost or liability or the duty to notify any other person, nor any incidents under internal
 review or investigations relating to the same. The Company and its subsidiaries are presently in material compliance with all applicable
 laws or statutes and all judgments, orders, rules and regulations of any court or arbitrator or governmental or regulatory authority,
 internal policies and contractual obligations relating to the privacy and security of IT Systems, Confidential Data, and Personal
 Data and to the protection of such IT Systems, Confidential Data, and Personal Data from unauthorized use, access, misappropriation
 or modification.

---

| | |
|:---|:---|
| (aaa) | <u>Compliance with Data Privacy Laws</u>. The Company and its subsidiaries are, and at all prior times were, in material compliance with all applicable state and federal data privacy and security laws and regulations, including without limitation HIPAA, CCPA, and GDPR (collectively, the "**<u>Privacy Laws</u>**"). To ensure compliance with the Privacy Laws, the Company has in place, complies with, and takes appropriate steps to ensure compliance in all material respects with their policies and procedures relating to data privacy and security and the collection, storage, use, processing, disclosure, handling, and analysis of Personal Data and Confidential Data (the "**<u>Policies</u>**"). The Company has at all times made all disclosures to users or customers required by applicable laws and regulatory rules or requirements, and none of such disclosures made or contained in any Policy have been inaccurate or in violation of any applicable laws and regulatory rules or requirements in any material respect. The Company further certifies that neither it nor any subsidiary: (i) has received notice of any actual or potential liability under or relating to, or actual or potential violation of, any of the Privacy Laws, and has no knowledge of any event or condition that would reasonably be expected to result in any such notice; (ii) is currently conducting or paying for, in whole or in part, any investigation, remediation, or other corrective action pursuant to any Privacy Law; or (iii) is a party to any order, decree, or agreement that imposes any obligation or liability under any Privacy Law. |
| (bbb) | <u>Emerging Growth Company Status</u>. From the time of the initial filing of the Company's first registration statement with the Commission through the date hereof, the Company has been and is an "emerging growth company," as defined in Section 2(a) of the Securities Act (an "**<u>Emerging Growth Company</u>**"). |
| (ccc) | <u>Smaller Reporting Company</u>. As of the time of filing of the Registration Statement, the Company was a "smaller reporting company," as defined in Rule 12b-2 of the Exchange Act. |
| (ddd) | <u>Loans to Directors or Officers</u>. There are no outstanding loans, advances (except normal advances for business expenses in the ordinary course of business) or guarantees or indebtedness by the Company or its Subsidiaries to or for the benefit of any of the officers or directors of the Company, its Subsidiaries or any of their respective family members, except as disclosed in the Registration Statement and the Prospectus. |
|  | Any certificate signed by an officer of the Company and delivered to the Agent or to counsel for the Agent pursuant to or in connection with this Agreement shall be deemed to be a representation and warranty by the Company, as applicable, to the Agent as to the matters set forth therein. |

---

7. <u>Covenants of the Company</u>. The Company covenants and agrees with the Agent that:

(a) <u>Registration Statement Amendments</u>. After the date of this Agreement and during any period in which a Prospectus relating to any Placement
 Shares is required to be delivered by the Agent under the Securities Act (including in circumstances where such requirement may be
 satisfied pursuant to Rule 172 under the Securities Act or similar rule), (i) the Company will notify the Agent promptly of the time
 when any subsequent amendment to the Registration Statement, other than documents incorporated by reference, has been filed with
 the Commission and/or has become effective or any subsequent supplement to the Prospectus has been filed and of any request by the
 Commission for any amendment or supplement to the Registration Statement or the Prospectus or for additional information, (ii) the
 Company will prepare and file with the Commission, promptly upon the Agent's request, any amendments or supplements
 to the Registration Statement or the Prospectus that, in the Agent's reasonable opinion, may be necessary or advisable
 in connection with the distribution of the Placement Shares by the Agent (*provided*, *however*, that the failure of the
 Agent to make such request shall not relieve the Company of any obligation or liability hereunder, or affect the Agent's
 right to rely on the representations and warranties made by the Company in this Agreement and *provided*, *further*, that
 the only remedy the Agent shall has with respect to the failure to make such filing shall be to cease making sales under this
 Agreement until such amendment or supplement is filed); (iii) the Company will not file any amendment or supplement to the Registration
 Statement or the Prospectus relating to the Placement Shares or a security convertible into the Placement Shares unless a copy thereof
 has been submitted to the Agent within a reasonable period of time before the filing and the Agent have not objected thereto (*provided*, *however*, that the failure of the Agent to make such objection shall not relieve the Company of any obligation or liability
 hereunder, or affect the Agent's right to rely on the representations and warranties made by the Company in this Agreement
 and *provided*, *further*, that the only remedy the Agent shall have with respect to the failure by the Company to obtain
 such consent shall be to cease making sales under this Agreement) and the Company will furnish to the Agent at the time of filing
 thereof a copy of any document that upon filing is deemed to be incorporated by reference into the Registration Statement or the
 Prospectus, except for those documents available via EDGAR; and (iv) the Company will cause each amendment or supplement to the Prospectus
 to be filed with the Commission as required pursuant to the applicable paragraph of Rule 424(b) of the Securities Act or, in the
 case of any document to be incorporated therein by reference, to be filed with the Commission as required pursuant to the Exchange
 Act, within the time period prescribed (the determination to file or not file any amendment or supplement with the Commission under
 this <u>Section 7(a)</u>, based on the Company's reasonable opinion or reasonable objections, shall be made exclusively by
 the Company).

(b) <u>Notice of Commission Stop Orders</u>. The Company will advise the Agent, promptly after it receives notice or obtains knowledge thereof,
 of the issuance or threatened issuance by the Commission of any stop order suspending the effectiveness of the Registration Statement,
 of the suspension of the qualification of the Placement Shares for offering or sale in any jurisdiction, or of the initiation or
 threatening of any proceeding for any such purpose; and it will promptly use its commercially reasonable efforts to prevent the issuance
 of any stop order or to obtain its withdrawal if such a stop order should be issued. The Company will advise the Agent promptly
 after it receives any request by the Commission for any amendments to the Registration Statement or any amendment or supplements
 to the Prospectus or any Issuer Free Writing Prospectus or for additional information related to the offering of the Placement Shares
 or for additional information related to the Registration Statement, the Prospectus or any Issuer Free Writing Prospectus.

(c) <u>Delivery of Prospectus; Subsequent Changes</u>. During any period in which a Prospectus relating to the Placement Shares is required to be
 delivered by the Agent under the Securities Act with respect to the offer and sale of the Placement Shares, (including in circumstances
 where such requirement may be satisfied pursuant to Rule 172 under the Securities Act or similar rule), the Company will comply with
 all requirements imposed upon it by the Securities Act, as from time to time in force, and to file on or before their respective
 due dates all reports and any definitive proxy or information statements required to be filed by the Company with the Commission
 pursuant to Sections 13(a), 13(c), 14, 15(d) or any other provision of or under the Exchange Act. If the Company has omitted any
 information from the Registration Statement pursuant to Rule 430B under the Securities Act, it will use its best efforts to comply
 with the provisions of and make all requisite filings with the Commission pursuant to said Rule 430B and to notify the Agent promptly
 of all such filings. If during such period (i) any event occurs as a result of which the Prospectus as then amended or supplemented
 would include an untrue statement of a material fact or omit to state a material fact necessary to make the statements therein, in
 the light of the circumstances then existing, not misleading, or (ii) for any other reason it shall be necessary during such same
 period to amend or supplement the Prospectus, to file any post-effective amendment to the Registration Statement or to file under
 the Exchange Act any document incorporated by reference in the Prospectus in order to comply with the Securities Act or the Exchange
 Act, the Company will promptly notify the Agent to suspend the offering of Placement Shares during such period and the Company will
 promptly amend or supplement the Registration Statement or the Prospectus (at the expense of the Company) so as to correct such statement
 or omission or effect such compliance and to prepare and furnish without charge to the Agent and to any dealer in securities as
 many written and electronic copies as the Agent may from time to time reasonably request of an amended Prospectus or a supplement
 to the Prospectus which will correct such statement or omission or effect such compliance.

(d) <u>Listing of Placement Shares</u>. Prior to the date of the first Placement Notice, the Company will use its reasonable best efforts to cause
 the Placement Shares to be listed on the Exchange.

(e) <u>Delivery of Registration Statement and Prospectus</u>. The Company will furnish to the Agent and their counsel (at the expense of the Company)
 copies of the Registration Statement, the Prospectus (including all documents incorporated by reference therein) and all amendments
 and supplements to the Registration Statement or the Prospectus that are filed with the Commission during any period in which a Prospectus
 relating to the Placement Shares is required to be delivered under the Securities Act (including all documents filed with the Commission
 during such period that are deemed to be incorporated by reference therein), in each case as soon as reasonably practicable and in
 such quantities as the Agent may from time to time reasonably request and, at the Agent's request, will also furnish
 copies of the Prospectus to each exchange or market on which sales of the Placement Shares may be made; *provided*, *however*,
 that the Company shall not be required to furnish any document (other than the Prospectus) to the Agent to the extent such document
 is available on EDGAR.

(f) <u>Earning Statement</u>. The Company will make generally available to its security holders as soon as practicable, but in any event not later
 than 15 months after the end of the Company's current fiscal quarter, an earning statement covering a 12-month period that
 satisfies the provisions of Section 11(a) and Rule 158 of the Securities Act (except to the extent posted on EDGAR).

(g) <u>Use of Proceeds</u>. The Company will use the Net Proceeds as described in the Prospectus in the section entitled "Use of Proceeds."

(h) <u>Notice of Other Sales</u>. Without the prior written consent of the Agent, the Company will not, directly or indirectly, offer to sell,
 sell, contract to sell, grant any option to sell or otherwise dispose of any Common Stock (other than the Placement Shares offered
 pursuant to this Agreement) or securities convertible into or exchangeable for Common Stock, warrants or any rights to purchase or
 acquire, Common Stock during the period beginning on the fifth (5<sup>th</sup>) Trading Day immediately prior to the date on which
 any Placement Notice is delivered to the Agent hereunder and ending on the fifth (5<sup>th</sup>) Trading Day immediately following
 the final Settlement Date with respect to Placement Shares sold pursuant to such Placement Notice (or, if the Placement Notice has
 been terminated or suspended prior to the sale of all Placement Shares covered by a Placement Notice, the date of such suspension
 or termination); and will not directly or indirectly in any other "at the market" or continuous equity transaction offer
 to sell, sell, contract to sell, grant any option to sell or otherwise dispose of any Common Stock (other than the Placement Shares
 offered pursuant to this Agreement) or securities convertible into or exchangeable for Common Stock, warrants or any rights to purchase
 or acquire, Common Stock prior to the sixtieth (60<sup>th</sup>) day immediately following the termination of this Agreement; *provided*, *however*, that such restrictions will not be required in connection with the Company's issuance or sale of (i) Common
 Stock, options to purchase Common Stock or Common Stock issuable upon the exercise of options, pursuant to any employee or director
 stock option or benefits plan, stock ownership plan or dividend reinvestment plan (but not Common Stock subject to a waiver to exceed
 plan limits in its dividend reinvestment plan) of the Company whether now in effect or hereafter implemented, (ii) Common Stock issuable
 upon conversion of securities or the exercise of warrants, options or other rights in effect or outstanding, and disclosed in filings
 by the Company available on EDGAR or otherwise in writing to the Agent and (iii) Common Stock or securities convertible into or
 exchangeable for shares of Common Stock as consideration for mergers, acquisitions, other business combinations or strategic alliances
 occurring after the date of this Agreement which are not issued for capital raising purposes.

(i) <u>Change of Circumstances</u>. The Company will, at any time during the pendency of a Placement Notice, advise the Agent promptly after it
 shall have received notice or obtained knowledge thereof, of any information or fact that would alter or affect in any material respect
 any opinion, certificate, letter or other document required to be provided to the Agent pursuant to this Agreement.

(j) <u>Due Diligence Cooperation</u>. The Company will cooperate with any reasonable due diligence review conducted by the Agent or their representatives
 in connection with the transactions contemplated hereby, including, without limitation, providing information and making available
 documents and senior corporate officers, during regular business hours and at the Company's principal offices, as the Agent
 may reasonably request.

(k) <u>Required Filings Relating to Placement of Placement Shares</u>. The Company shall disclose, in its Quarterly Reports on Form 10-Q and in its
 Annual Report on Form 10-K to be filed by the Company with the Commission from time to time, the number of the Placement Shares sold
 through the Agent under this Agreement, and the net proceeds to the Company from the sale of the Placement Shares pursuant to this
 Agreement during the relevant quarter or, in the case of an Annual Report on Form 10-K, during the fiscal year covered by such Annual
 Report and the fourth quarter of such fiscal year. The Company agrees that on such dates as the Securities Act shall require, the
 Company will (i) file a prospectus supplement with the Commission under the applicable paragraph of Rule 424(b) under the Securities
 Act (each and every filing date under Rule 424(b), a "  **<u>Filing Date</u>** "), which prospectus supplement will set
 forth, within the relevant period, the amount of Placement Shares sold through the Agent, the Net Proceeds to the Company and the
 compensation payable by the Company to the Agent with respect to such Placement Shares, and (ii) deliver such number of copies of
 each such prospectus supplement to each exchange or market on which such sales were effected as may be required by the rules or regulations
 of such exchange or market.

(l) <u>Representation Dates; Certificate</u>. (1) Prior to the date of the first Placement Notice and (2) each time the Company:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) files the Prospectus relating to the Placement Shares or amends or supplements (other than a prospectus supplement relating solely to an offering of securities other than the Placement Shares) the Registration Statement or the Prospectus relating to the Placement Shares by means of a post-effective amendment, sticker, or supplement but not by means of incorporation of documents by reference into the Registration Statement or the Prospectus relating to the Placement Shares;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) files an Annual Report on Form 10-K under the Exchange Act (including any Annual Report on Form 10-K/A containing amended or restated financial information or a material amendment to the previously filed Annual Report on Form 10-K);

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii) files its Quarterly Reports on Form 10-Q under the Exchange Act; or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iv) files a Current Report on Form 8-K containing amended financial information (other than information "furnished" pursuant to Items 2.02 or 7.01 of Form 8-K or to provide disclosure pursuant to Item 8.01 of Form 8-K relating to the reclassification of certain properties as discontinued operations in accordance with Statement of Financial Accounting Standards No. 144) under the Exchange Act (each date of filing of one or more of the documents referred to in clauses (i) through (iv) shall be a "**<u>Representation Date</u>**");

the Company shall furnish the Agent (but in the case of clause (iv) above only if the Agent reasonably determine that the information contained in such Current Report on Form 8-K is material) with a certificate dated the Representation Date, in the form and substance satisfactory to the Agent and its counsel, substantially similar to the form previously provided to the Agent and their counsel, modified, as necessary, to relate to the Registration Statement and the Prospectus as amended or supplemented. The requirement to provide a certificate under this <u>Section 7(l)</u> shall be waived for any Representation Date occurring at a time a Suspension is in effect, which waiver shall continue until the earlier to occur of the date the Company delivers instructions for the sale of Placement Shares hereunder (which for such calendar quarter shall be considered a Representation Date) and the next occurring Representation Date. Notwithstanding the foregoing, if the Company subsequently decides to sell Placement Shares following a Representation Date when a Suspension was in effect and did not provide the Agent with a certificate under this <u>Section 7(l)</u>, then before the Company delivers the instructions for the sale of Placement Shares or the Agent sell any Placement Shares pursuant to such instructions, the Company shall provide the Agent with a certificate in conformity with this <u>Section 7(l)</u> dated as of the date that the instructions for the sale of Placement Shares are issued.

(m) <u>Legal Opinion</u>. (1) Prior to the date of the first Placement Notice and (2) within five (5) Trading Days of each Representation Date
 with respect to which the Company is obligated to deliver a certificate pursuant to <u>Section 7(l)</u> for which no Suspension or
 waiver is applicable and excluding the date of this Agreement, the Company shall cause to be furnished to the Agent a written opinion
 and negative assurance letter of Winston & Strawn LLP ("  **<u>Company Counsel</u>** "), in form and substance reasonably
 satisfactory to the Agent and its counsel; *provided*, that in lieu of such opinions or negative assurance letters
 for subsequent periodic filings under the Exchange Act, counsel may furnish the Agent with a letter (a "  **<u>Reliance Letter</u>** ")
 to the effect that the Agent may rely on a prior opinion or negative assurance letter delivered under this <u>Section 7(m)</u> to
 the same extent as if it were dated the date of such letter (except that statements in such prior opinion or negative assurance letter,
 as the case may be, shall be deemed to relate to the Registration Statement and the Prospectus as amended or supplemented as of the
 date of the Reliance Letter).

(n) <u>Comfort Letter</u>. (1) Prior to the date of the first Placement Notice and (2) within five (5) Trading Days of each Representation Date
 with respect to which the Company is obligated to deliver a certificate pursuant to <u>Section 7(l)</u> for which no waiver is applicable
 and excluding the date of this Agreement, the Company shall cause the Accountant (and any other independent accountant whose report
 is included in or incorporated by reference into the Registration Statement or the Prospectus) to furnish the Agent letters (the
 "  **<u>Comfort Letters</u>** "), dated the date the Comfort Letter is delivered, which shall meet the requirements set
 forth in this <u>Section 7(n)</u>; *provided*, that if requested by the Agent, the Company shall cause a Comfort Letter to
 be furnished to the Agent within ten (10) Trading Days after the date of occurrence of any material transaction or event requiring
 the filing of a Current Report on Form 8-K containing financial information (including the restatement of the Company's financial
 statements). The Comfort Letter from the Accountant (and any other independent accountant whose report is included in or incorporated
 by reference into the Registration Statement or the Prospectus) shall be in a form and substance satisfactory to the Agent, (i)
 confirming that they are an independent registered public accounting firm within the meaning of the Securities Act and the PCAOB,
 (ii) stating, as of such date, the conclusions and findings of such firm with respect to the financial information and other matters
 ordinarily covered by accountants' "comfort letters" to underwriters in connection with registered public offerings
 (the first such letter, the "  **<u>Initial Comfort Letter</u>**") and (iii) updating the Initial Comfort Letter with
 any information that would have been included in the Initial Comfort Letter had it been given on such date and modified as necessary
 to relate to the Registration Statement and the Prospectus, as amended and supplemented to the date of such letter.

(o) <u>Market Activities; Compliance with Regulation M</u>. The Company will not, directly or indirectly, (i) take any action designed to cause
 or result in, or that constitutes or would reasonably be expected to constitute, the stabilization or manipulation of the price of
 any security of the Company to facilitate the sale or resale of Common Stock or (ii) sell, bid for, or purchase Common Stock in violation
 of Regulation M, or pay anyone any compensation for soliciting purchases of the Placement Shares other than the Agent.

(p) <u>Investment Company Act</u>. The Company will conduct its affairs in such a manner so as to reasonably ensure that neither it nor any of its
 Subsidiaries will be or become, at any time prior to the termination of this Agreement, required to register as an "investment
 company," as such term is defined in the Investment Company Act.

(q) <u>No Offer to Sell</u>. Other than an Issuer Free Writing Prospectus approved in advance by the Company and the Agent in their capacity
 as agent hereunder, neither the Agent nor the Company (including its agents and representatives, other than the Agent in its
 capacity as such) will make, use, prepare, authorize, approve or refer to any written communication (as defined in Rule 405 under
 the Securities Act), required to be filed with the Commission, that constitutes an offer to sell or solicitation of an offer to buy
 Placement Shares hereunder.

(r) <u>Blue Sky and Other Qualifications</u> *.* The Company will use its commercially reasonable efforts, in cooperation with the Agent,
 to qualify the Placement Shares for offering and sale, or to obtain an exemption for the Placement Shares to be offered and sold,
 under the applicable securities laws of such states and other jurisdictions (domestic or foreign) as the Agent may designate and
 to maintain such qualifications and exemptions in effect for so long as required for the distribution of the Placement Shares (but
 in no event for less than one year from the date of this Agreement); *provided*, *however*, that the Company shall not
 be obligated to file any general consent to service of process or to qualify as a foreign corporation or as a dealer in securities
 in any jurisdiction in which it is not so qualified or to subject itself to taxation in respect of doing business in any jurisdiction
 in which it is not otherwise so subject. In each jurisdiction in which the Placement Shares have been so qualified or exempt, the
 Company will file such statements and reports as may be required by the laws of such jurisdiction to continue such qualification
 or exemption, as the case may be, in effect for so long as required for the distribution of the Placement Shares (but in no event
 for less than one year from the date of this Agreement).

(s) <u>Sarbanes-Oxley Act</u>. The Company and the Subsidiaries will maintain and keep accurate books and records reflecting their assets and maintain
 internal accounting controls in a manner designed to provide reasonable assurance regarding the reliability of financial reporting
 and the preparation of financial statements for external purposes in accordance with GAAP and including those policies and procedures
 that (i) pertain to the maintenance of records that in reasonable detail accurately and fairly reflect the transactions and dispositions
 of the assets of the Company, (ii) provide reasonable assurance that transactions are recorded as necessary to permit the preparation
 of the Company's consolidated financial statements in accordance with GAAP, (iii) that receipts and expenditures of the Company
 are being made only in accordance with management's and the Company's directors' authorization, and (iv) provide
 reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of the Company's
 assets that could have a material effect on its financial statements. The Company and the Subsidiaries will maintain such controls
 and other procedures, including, without limitation, those required by Sections 302 and 906 of the Sarbanes-Oxley Act, and the applicable
 regulations thereunder that are designed to ensure that information required to be disclosed by the Company in the reports that it
 files or submits under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the
 Commission's rules and forms, including, without limitation, controls and procedures designed to ensure that information required
 to be disclosed by the Company in the reports that it files or submits under the Exchange Act is accumulated and communicated to
 the Company's management, including its principal executive officer and principal financial officer, or persons performing
 similar functions, as appropriate to allow timely decisions regarding required disclosure and to ensure that material information
 relating to the Company or the Subsidiaries is made known to them by others within those entities, particularly during the period
 in which such periodic reports are being prepared.

(t) <u>Secretary's Certificate; Further Documentation</u>. Prior to the date of the first Placement Notice, the Company shall deliver to the Agent
 a certificate of the Secretary of the Company and attested to by an executive officer of the Company, dated as of such date, certifying
 as to (i) the Certificate of Incorporation of the Company, as amended, (ii) the Bylaws of the Company, (iii) the resolutions of the
 Board of Directors of the Company authorizing the execution, delivery and performance of this Agreement and the issuance of the Placement
 Shares and (iv) the incumbency of the officers duly authorized to execute this Agreement and the other documents contemplated by
 this Agreement. Within five (5) Trading Days of each Representation Date, the Company shall have furnished to the Agent such further
 information, certificates and documents as the Agent may reasonably request.

(u) <u>Emerging Growth Company Status</u>. The Company will promptly notify the Agent if the Company ceases to be an Emerging Growth Company at any
 time during the term of this Agreement.

8. <u>Payment of Expenses</u>. The Company will pay all expenses incident to the performance of its obligations under this Agreement, including
 (i) the preparation and filing of the Registration Statement, including any fees required by the Commission, and the printing or
 electronic delivery of the Prospectus as originally filed and of each amendment and supplement thereto, in such number as the Agent
 shall deem necessary, (ii) the printing and delivery to the Agent of this Agreement and such other documents as may be required in
 connection with the offering, purchase, sale, issuance or delivery of the Placement Shares, (iii) the preparation, issuance and delivery
 of the certificates, if any, for the Placement Shares to the Agent, including any stock or other transfer taxes and any capital duties,
 stamp duties or other duties or taxes payable upon the sale, issuance or delivery of the Placement Shares to the Agent, (iv) the
 fees and disbursements of the counsel, accountants and other advisors to the Company, (v) the fees and expenses of the Agent including
 but not limited to the fees and expenses of the counsel to the Agent, payable upon the execution of this Agreement, (a) in an amount
 not to exceed $150,000 in connection with the execution of this Agreement, (b) in an amount not to exceed $25,000 per calendar quarter
 thereafter payable in connection with each Representation Date with respect to which the Company is obligated to deliver a certificate
 pursuant to <u>Section 7(l)</u> for which no waiver is applicable and excluding the date of this Agreement, and (c) in an amount
 not to exceed $40,000 for each program "refresh" (filing of a new registration statement, prospectus or prospectus supplement
 relating to the Placement Shares and/or an amendment of this Agreement) executed pursuant to this Agreement, (vi) the qualification
 or exemption of the Placement Shares under state securities laws in accordance with the provisions of <u>Section 7(r)</u> hereof,
 including filing fees, but excluding fees of the Agent's counsel, (vii) the printing and delivery to the Agent of copies
 of any Permitted Issuer Free Writing Prospectus and the Prospectus and any amendments or supplements thereto in such number as the
 Agent shall deem necessary, (viii) the preparation, printing and delivery to the Agent of copies of the blue sky survey, (ix) the
 fees and expenses of the transfer agent and registrar for the Common Stock, (x) the filing and other fees incident to any review
 by FINRA of the terms of the sale of the Placement Shares including the fees of the Agent's counsel (subject to the
 cap, set forth in clause (v) above), and (xi) the fees and expenses incurred in connection with the listing of the Placement Shares
 on the Exchange. The Company agrees to pay the fees and expenses of counsel to the Agent set forth in clause (v) above by wire transfer
 of immediately available funds directly to such counsel upon presentation of an invoice containing the requisite payment information
 prepared by such counsel, and such counsel shall be a third-party beneficiary of the expense reimbursement obligations set forth
 in this <u>Section 8</u>.

9. <u>Conditions to the Agent's Obligations</u>. The obligations of the Agent hereunder with respect to a Placement will be subject to
 the continuing accuracy and completeness of the representations and warranties made by the Company herein, to the due performance
 by the Company of its obligations hereunder, to the completion by the Agent of a due diligence review satisfactory to it in its reasonable
 judgment, and to the continuing satisfaction (or waiver by the Agent in its sole discretion) of the following additional
 conditions:

(a) <u>Registration Statement Effective</u>. The Registration Statement shall have become effective and shall be available for the (i) resale of all
 Placement Shares issued to the Agent and not yet sold by the Agent and (ii) sale of all Placement Shares contemplated to be issued
 by any Placement Notice.

(b) <u>No Material Notices</u>. None of the following events shall have occurred and be continuing: (i) receipt by the Company of any request
 for additional information from the Commission or any other federal or state Governmental Authority during the period of effectiveness
 of the Registration Statement, the response to which would require any post-effective amendments or supplements to the Registration
 Statement or the Prospectus; (ii) the issuance by the Commission or any other federal or state Governmental Authority of any stop
 order suspending the effectiveness of the Registration Statement or the initiation of any proceedings for that purpose; (iii) receipt
 by the Company of any notification with respect to the suspension of the qualification or exemption from qualification of any of
 the Placement Shares for sale in any jurisdiction or the initiation or threatening of any proceeding for such purpose; or (iv) the
 occurrence of any event that makes any statement of a material fact made in the Registration Statement or the Prospectus or any document
 incorporated or deemed to be incorporated therein by reference untrue or that requires the making of any changes in the Registration
 Statement, the Prospectus or any such documents so that, in the case of the Registration Statement, it will not contain an untrue
 statement of a material fact or omit to state any material fact required to be stated therein or necessary in order to make the statements
 therein not misleading and, that in the case of the Prospectus, it will not contain an untrue statement of a material fact or omit
 to state a material fact required to be stated therein or necessary in order to make the statements therein, in the light of the
 circumstances under which they were made, not misleading.

(c) <u>No Misstatement or Material Omission</u>. The Agent shall not have advised the Company that the Registration Statement or the Prospectus,
 or any amendment or supplement thereto, contains an untrue statement of fact that in the Agent's reasonable opinion
 is material, or omits to state a fact that in the Agent's reasonable opinion is material and is required to be stated
 therein or is necessary to make the statements therein not misleading.

(d) <u>Material Changes</u>. Except as contemplated in the Registration Statement or the Prospectus, or disclosed in the Company's reports
 filed with the Commission, there shall not have been any material adverse change in the authorized capital stock of the Company or
 any Material Adverse Effect or any development that would cause a Material Adverse Effect, or a downgrading in or withdrawal of the
 rating assigned to any of the Company's securities (other than asset backed securities) by any rating organization or a public
 announcement by any rating organization that it has under surveillance or review its rating of any of the Company's securities
 (other than asset backed securities), the effect of which, in the case of any such action by a rating organization described above,
 in the reasonable judgment of the Agent (without relieving the Company of any obligation or liability it may otherwise have), is
 so material as to make it impracticable or inadvisable to proceed with the offering of the Placement Shares on the terms and in the
 manner contemplated in the Prospectus.

(e) <u>Legal Opinions</u>. The Agent shall have received the opinions and negative assurance letters of Company Counsel required to be delivered
 pursuant to <u>Section 7(m)</u> on or before the date on which such delivery of such opinions and negative assurance letters, as
 applicable, is required pursuant to <u>Section 7(m)</u>.

(f) <u>Comfort Letter</u>. The Agent shall have received the Comfort Letter required to be delivered pursuant to <u>Section 7(n)</u> on or before
 the date on which such delivery of such Comfort Letter is required pursuant to <u>Section 7(n)</u>.

(g) <u>Representation Certificate</u>. The Agent shall have received the certificate required to be delivered pursuant to <u>Section 7(l)</u> on or before
 the date on which delivery of such certificate is required pursuant to <u>Section 7(l)</u>.

(h) <u>No Suspension</u>. Trading in the Common Stock shall not have been suspended on the Exchange and the Common Stock shall not have been
 delisted from the Exchange.

(i) <u>Other Materials</u>. On each date on which the Company is required to deliver a certificate pursuant to <u>Section 7(l)</u>, the Company
 shall have furnished to the Agent such appropriate further information, opinions, certificates, letters and other documents as the
 Agent may reasonably request. All such opinions, certificates, letters and other documents will be in compliance with the provisions
 hereof.

(j) <u>Securities Act Filings Made</u>. All filings with the Commission required by Rule 424 under the Securities Act to have been filed prior to the
 issuance of any Placement Notice hereunder shall have been made within the applicable time period prescribed for such filing by Rule

(k) <u>Approval for Listing</u>. The Placement Shares shall either have been (i) approved for listing on the Exchange, subject only to notice of
 issuance, or (ii) the Company shall have filed an application for listing of the Placement Shares on the Exchange at, or prior to,
 the issuance of any Placement Notice and the Exchange shall have reviewed such application and not provided any objections thereto.

(l) <u>FINRA</u>.
 If applicable, FINRA shall have raised no objection to the terms of this offering and the amount of compensation allowable or payable
 to the Agent as described in the Prospectus.

(m) <u>No Termination Event</u>. There shall not have occurred any event that would permit the Agent to terminate this Agreement pursuant
 to <u>Section 12(a)</u>.

10. <u>Indemnification and Contribution</u>.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) <u>Company Indemnification</u>. The Company agrees to indemnify and hold harmless the Agent, its affiliates and their respective partners, members, directors, officers, employees and agents and each person, if any, who controls the Agent or any affiliate within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act as follows:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) against any and all loss, liability, claim, damage and expense whatsoever, as incurred, joint or several, arising out of or based upon any untrue statement or alleged untrue statement of a material fact contained in the Registration Statement (or any amendment thereto), or the omission or alleged omission therefrom of a material fact required to be stated therein or necessary to make the statements therein not misleading, or arising out of any untrue statement or alleged untrue statement of a material fact included in any related Issuer Free Writing Prospectus or the Prospectus (or any amendment or supplement thereto), or the omission or alleged omission therefrom of a material fact necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) against any and all loss, liability, claim, damage and expense whatsoever, as incurred, joint or several, to the extent of the aggregate amount paid in settlement of any litigation, or any investigation or proceeding by any Governmental Authority, commenced or threatened, or of any claim whatsoever based upon any such untrue statement or omission, or any such alleged untrue statement or omission; *provided* that (subject to <u>Section 10(d)</u> below) any such settlement is effected with the written consent of the Company, which consent shall not unreasonably be delayed or withheld; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii) against any and all expense whatsoever, as incurred (including the fees and disbursements of counsel), reasonably incurred in investigating, preparing or defending against any litigation, or any investigation or proceeding by any Governmental Authority, commenced or threatened, or any claim whatsoever based upon any such untrue statement or omission, or any such alleged untrue statement or omission (whether or not a party), to the extent that any such expense is not paid under (i) or (ii) above,

*provided*, *however*, that this indemnity agreement shall not apply to any loss, liability, claim, damage or expense to the extent arising out of any untrue statement or omission or alleged untrue statement or omission made solely in reliance upon and in conformity with the Agent's Information (defined below).

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) <u>Agent Indemnification</u>. The Agent agrees to indemnify and hold harmless the Company and its directors and each officer of the Company who signed the Registration Statement, and each person, if any, who controls the Company within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act against any and all loss, liability, claim, damage and expense described in the indemnity contained in <u>Section 10(a)</u>, as incurred, but only with respect to untrue statements or omissions, or alleged untrue statements or omissions, made in the Registration Statement (or any amendments thereto), the Prospectus, any Prospectus Supplement (or any amendment or supplement thereto) or any Issuer Free Writing Prospectus (or any amendment or supplement thereto) in reliance upon and in conformity with information relating to such Agent and furnished to the Company in writing by such Agent expressly for use therein. The Company hereby acknowledges that the only information that the Agent has furnished to the Company expressly for use in the Registration Statement, the Prospectus, any Prospectus Supplement or any Issuer Free Writing Prospectus (or any amendment or supplement thereto) are the statements set forth in the [first sentence of the fifth paragraph and the seventh and eighth paragraphs under the caption "Plan of Distribution"]<sup>1</sup> in the Sales Prospectus (the "**<u>Agent's</u> <u>Information</u>**").

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) <u>Procedure</u>. Any party that proposes to assert the right to be indemnified under this <u>Section 10</u> will, promptly after receipt of notice of commencement of any action against such party in respect of which a claim is to be made against an indemnifying party or parties under this <u>Section 10</u>, notify each such indemnifying party of the commencement of such action, enclosing a copy of all papers served, but the omission so to notify such indemnifying party will not relieve the indemnifying party from (i) any liability that it might have to any indemnified party otherwise than under this <u>Section 10</u> and (ii) any liability that it may have to any indemnified party under the foregoing provision of this <u>Section 10</u> unless, and only to the extent that, such omission results in the forfeiture of substantive rights or defenses by the indemnifying party. If any such action is brought against any indemnified party and it notifies the indemnifying party of its commencement, the indemnifying party will be entitled to participate in and, to the extent that it elects by delivering written notice to the indemnified party promptly after receiving notice of the commencement of the action from the indemnified party, jointly with any other indemnifying party similarly notified, to assume the defense of the action, with counsel reasonably satisfactory to the indemnified party, and after notice from the indemnifying party to the indemnified party of its election to assume the defense, the indemnifying party will not be liable to the indemnified party for any other legal expenses except as provided below and except for the reasonable costs of investigation subsequently incurred by the indemnified party in connection with the defense. The indemnified party will have the right to employ its own counsel in any such action, but the fees, expenses and other charges of such counsel will be at the expense of such indemnified party unless (1) the employment of counsel by the indemnified party has been authorized in writing by the indemnifying party, (2) the indemnified party has reasonably concluded (based on advice of counsel) that there may be legal defenses available to it or other indemnified parties that are different from or in addition to those available to the indemnifying party, (3) a conflict or potential conflict exists (based on advice of counsel to the indemnified party) between the indemnified party and the indemnifying party (in which case the indemnifying party will not have the right to direct the defense of such action on behalf of the indemnified party) or (4) the indemnifying party has not in fact employed counsel to assume the defense of such action or counsel reasonably satisfactory to the indemnified party, in each case, within a reasonable time after receiving notice of the commencement of the action; in each of which cases the reasonable fees, disbursements and other charges of counsel will be at the expense of the indemnifying party or parties. It is understood that the indemnifying party or parties shall not, in connection with any proceeding or related proceedings in the same jurisdiction, be liable for the reasonable fees, disbursements and other charges of more than one separate firm (plus local counsel) admitted to practice in such jurisdiction at any one time for all such indemnified party or parties. All such fees, disbursements and other charges will be reimbursed by the indemnifying party promptly as they are incurred. An indemnifying party will not, in any event, be liable for any settlement of any action or claim effected without its written consent. No indemnifying party shall, without the prior written consent of each indemnified party, settle or compromise or consent to the entry of any judgment in any pending or threatened claim, action or proceeding relating to the matters contemplated by this <u>Section 10</u> (whether or not any indemnified party is a party thereto), unless such settlement, compromise or consent (1) includes an express and unconditional release of each indemnified party, in form and substance reasonably satisfactory to such indemnified party, from all liability arising out of such litigation, investigation, proceeding or claim and (2) does not include a statement as to or an admission of fault, culpability or a failure to act by or on behalf of any indemnified party.

_________________________

<sup>1</sup> **NTD**: To be updated to match final pro supp disclosure.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) <u>Settlement Without Consent if Failure to Reimburse</u>*.* If an indemnified party shall have requested an indemnifying party to reimburse the indemnified party for reasonable fees and expenses of counsel, such indemnifying party agrees that it shall be liable for any settlement of the nature contemplated by <u>Section 10(a)(ii)</u> effected without its written consent if (1) such settlement is entered into more than 45 days after receipt by such indemnifying party of the aforesaid request, (2) such indemnifying party shall have received notice of the terms of such settlement at least 30 days prior to such settlement being entered into and (3) such indemnifying party shall not have reimbursed such indemnified party in accordance with such request prior to the date of such settlement.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e) <u>Contribution</u>. In order to provide for just and equitable contribution in circumstances in which the indemnification provided for in the foregoing paragraphs of this <u>Section 10</u> is applicable in accordance with its terms but for any reason is held to be unavailable or insufficient from the Company or the Agent, the Company and the Agent will contribute to the total losses, claims, liabilities, expenses and damages (including any investigative, legal and other expenses reasonably incurred in connection with, and any amount paid in settlement of, any action, suit or proceeding or any claim asserted) to which the Company and the Agent may be subject in such proportion as shall be appropriate to reflect the relative benefits received by the Company on the one hand and the Agent on the other hand. The relative benefits received by the Company on the one hand and the Agent on the other hand shall be deemed to be in the same proportion as the total net proceeds from the sale of the Placement Shares (before deducting expenses) received by the Company bear to the total compensation received by the Agent from the sale of Placement Shares on behalf of the Company. If, but only if, the allocation provided by the foregoing sentence is not permitted by applicable law, the allocation of contribution shall be made in such proportion as is appropriate to reflect not only the relative benefits referred to in the foregoing sentence but also the relative fault of the Company, on the one hand, and the Agent, on the other hand, with respect to the statements or omission that resulted in such loss, claim, liability, expense or damage, or action in respect thereof, as well as any other relevant equitable considerations with respect to such offering. Such relative fault shall be determined by reference to, among other things, whether the untrue or alleged untrue statement of a material fact or omission or alleged omission to state a material fact relates to information supplied by the Company or the Agent, the intent of the parties and their relative knowledge, access to information and opportunity to correct or prevent such statement or omission. The Company and the Agent agree that it would not be just and equitable if contributions pursuant to this <u>Section 10(e)</u> were to be determined by pro rata allocation or by any other method of allocation that does not take into account the equitable considerations referred to herein. The amount paid or payable by an indemnified party as a result of the loss, claim, liability, expense, or damage, or action in respect thereof, referred to above in this <u>Section 10(e)</u> shall be deemed to include, for the purpose of this <u>Section 10(e)</u>, any legal or other expenses reasonably incurred by such indemnified party in connection with investigating or defending any such action or claim to the extent consistent with <u>Section 10(c)</u> hereof. Notwithstanding the foregoing provisions of this <u>Section 10(e)</u>, the Agent shall not be required to contribute any amount in excess of the commissions received by it under this Agreement and no person found guilty of fraudulent misrepresentation (within the meaning of <u>Section 11(f)</u> of the Securities Act) will be entitled to contribution from any person who was not guilty of such fraudulent misrepresentation. For purposes of this <u>Section 10(e)</u>, any person who controls a party to this Agreement within the meaning of the Securities Act, any affiliates of the Agent and any officers, directors, partners, employees or agents of the Agent or any of its affiliates, will have the same rights to contribution as that party, and each director of the Company and each officer of the Company who signed the Registration Statement will have the same rights to contribution as the Company, subject in each case to the provisions hereof. Any party entitled to contribution, promptly after receipt of notice of commencement of any action against such party in respect of which a claim for contribution may be made under this <u>Section 10(e)</u>, will notify any such party or parties from whom contribution may be sought, but the omission to so notify will not relieve that party or parties from whom contribution may be sought from any other obligation it or they may have under this <u>Section 10(e)</u> except to the extent that the failure to so notify such other party materially prejudiced the substantive rights or defenses of the party from whom contribution is sought. Except for a settlement entered into pursuant to the last sentence of <u>Section 10(c)</u> hereof, no party will be liable for contribution with respect to any action or claim settled without its written consent if such consent is required pursuant to <u>Section 10(c)</u> hereof. The Agents' respective obligations to contribute pursuant to this <u>Section 10(e)</u> are several in proportion to the respective number of Placement Shares they have sold hereunder, and not joint.

11. <u>Representations and Agreements to Survive Delivery</u>. The indemnity and contribution agreements contained in <u>Section 10</u> of this Agreement
 and all representations and warranties of the Company herein or in certificates delivered pursuant hereto shall survive, as of their
 respective dates, regardless of (i) any investigation made by or on behalf of the Agent, any controlling persons, or the Company
 (or any of their respective officers, directors, employees or controlling persons), (ii) delivery and acceptance of the Placement
 Shares and payment therefor or (iii) any termination of this Agreement.

12. <u>Termination</u>.

(a) The Agent may terminate this Agreement with respect to itself, by notice to the Company and the other Agents, as hereinafter specified
 at any time (1) if there has been, since the time of execution of this Agreement or since the date as of which information is given
 in the Prospectus, any change, or any development or event involving a prospective change, in the condition, financial or otherwise,
 or in the business, properties, earnings, results of operations or prospects of the Company and its Subsidiaries considered as one
 enterprise, whether or not arising in the ordinary course of business, which individually or in the aggregate, in the sole judgment
 of such Agent is material and adverse and makes it impractical or inadvisable to market the Placement Shares or to enforce contracts
 for the sale of the Placement Shares, (2) if there has occurred any material adverse change in the financial markets in the United
 States or the international financial markets, any outbreak of hostilities or escalation thereof or other calamity or crisis or any
 change or development involving a prospective change in national or international political, financial or economic conditions, in
 each case the effect of which is such as to make it, in the judgment of the Agent, impracticable or inadvisable to market
 the Placement Shares or to enforce contracts for the sale of the Placement Shares, (3) if trading in the Common Stock has been suspended
 or limited by the Commission or the Exchange, or if trading generally on the Exchange has been suspended or limited, or minimum prices
 for trading have been fixed on the Exchange, (4) if any suspension of trading of any securities of the Company on any exchange or
 in the over-the-counter market shall have occurred and be continuing, (5) if a major disruption of securities settlements or clearance
 services in the United States shall have occurred and be continuing, or (6) if a banking moratorium has been declared by either U.S.
 Federal or New York authorities. Any such termination shall be without liability of any party to any other party except that the
 provisions of <u>Section 8</u> (Payment of Expenses), <u>Section 10</u> (Indemnification and Contribution), <u>Section 11</u> (Representations
 and Agreements to Survive Delivery), <u>Section 17</u> (Governing Law and Time; Waiver of Jury Trial) and <u>Section 18</u> (Consent
 to Jurisdiction) hereof shall remain in full force and effect notwithstanding such termination. If the Agent elects to terminate
 this Agreement as provided in this <u>Section 12(a)</u>, such Agent shall provide the required notice as specified in <u>Section 13</u> (Notices). For the avoidance of doubt, the termination by one Agent of its rights and obligations under this Agreement pursuant
 to this <u>Section 12(a)</u> shall not affect the rights and obligations of the other Agents under this Agreement.

(b) The
 Company shall have the right, by giving ten (10) days' notice as hereinafter specified to terminate this Agreement in its sole
 discretion at any time after the date of this Agreement. Any such termination shall be without liability of any party to any other
 party except that the provisions of <u>Section 8</u>, <u>Section 10</u>, <u>Section 11</u>, <u>Section 17</u> and <u>Section 18</u> hereof shall remain in full force and effect notwithstanding such termination. For the avoidance of doubt, the termination by the
 Company of this Agreement with respect to one Agent pursuant to this <u>Section 12(b)</u> shall not affect the rights and obligations
 of the other Agents under this Agreement.

(c) The Agent shall have the right, by giving ten (10) days' notice as hereinafter specified to terminate this Agreement with respect
 to itself in its sole discretion at any time after the date of this Agreement. Any such termination shall be without liability of
 any party to any other party except that the provisions of <u>Section 8</u>, <u>Section 10</u>, <u>Section 11</u>, <u>Section 17</u> and <u>Section 18</u> hereof shall remain in full force and effect notwithstanding such termination. For the avoidance of doubt,
 the termination by one Agent of its rights and obligations under this Agreement pursuant to this <u>Section 12(c)</u> shall not affect
 the rights and obligations of the other Agents under this Agreement.

(d) This
 Agreement shall remain in full force and effect unless terminated pursuant to <u>Sections 12(a)</u>, <u>(b)</u>, or <u>(c)</u> above
 or otherwise by mutual agreement of the parties; *provided*, *however*, that any such termination by mutual agreement shall
 in all cases be deemed to provide that <u>Section 8</u>, <u>Section 10</u>, <u>Section 11</u>, <u>Section 17</u> and <u>Section 18</u> shall remain in full force and effect.

(e) Any
 termination of this Agreement shall be effective on the date specified in such notice of termination; *provided*, *however*,
 that such termination shall not be effective until the close of business on the date of receipt of such notice by the Agents or the
 Company, as the case may be. If such termination shall occur prior to the Settlement Date for any sale of Placement Shares, such
 Placement Shares shall settle in accordance with the provisions of this Agreement.

13. <u>Notices</u>.
 All notices or other communications required or permitted to be given by any party to any other party pursuant to the terms of this
 Agreement shall be in writing, unless otherwise specified, and if sent to the Agents, shall be delivered to:

R.F. Lafferty & Co., Inc.

40 Wall Street, Suite 3602

New York, New York 10005

Attention: Robert Hackel, Chief Operating Officer

Email: rhackel@rflafferty.com

with copies to:

Lucosky Brookman LLP

101 Wood Avenue South

Woodbridge \| New Jersey 08830

Attention: Lawrence Metelitsa

Email: lmetelitsa@lucbro.com

and if to the Company, shall be delivered to:

Eightco Holdings Inc.

101 Larry Holmes Dr., Suite 313

Easton, Pennsylvania 18042

Telephone: (888) 765-8933

Attention: Kevin O'Donnell

Email: ko@8co.holdings

with a copy to:

Winston & Strawn LLP

800 Capitol Street, Suite 2400

Houston, Texas 77002

Telephone: (713) 651-2600

Attention: Michael Blankenship

Email: mblankenship@winston.com

Each party to this Agreement may change such address for notices by sending to the parties to this Agreement written notice of a new address for such purpose. Each such notice or other communication shall be deemed given (i) when delivered personally or by verifiable facsimile transmission (with an original to follow) on or before 4:30 p.m., New York City time, on a Business Day or, if such day is not a Business Day, on the next succeeding Business Day, (ii) by Electronic Notice, as set forth below, (iii) on the next Business Day after timely delivery to a nationally-recognized overnight courier and (iv) on the Business Day actually received if deposited in the U.S. mail (certified or registered mail, return receipt requested, postage prepaid). For purposes of this Agreement, "**<u>Business Day</u>**" shall mean any day on which the Exchange and commercial banks in the City of New York are open for business.

An electronic communication ("**<u>Electronic Notice</u>**") shall be deemed written notice for purposes of this Section 13 if sent to the electronic mail address specified by the receiving party under separate cover. Electronic Notice shall be deemed received at the time the party sending Electronic Notice receives verification of receipt by the receiving party. Any party receiving Electronic Notice may request and shall be entitled to receive the notice on paper, in a nonelectronic form ("**<u>Nonelectronic Notic</u>e**") which shall be sent to the requesting party within ten (10) days of receipt of the written request for Nonelectronic Notice.

14. <u>Successors and Assigns</u>. This Agreement shall inure to the benefit of and be binding upon the Company and the Agent and their respective
 successors and the parties referred to in <u>Section 10</u> hereof. References to any of the parties contained in this Agreement
 shall be deemed to include the successors and permitted assigns of such party. Nothing in this Agreement, express or implied, is
 intended to confer upon any party other than the parties hereto or their respective successors and permitted assigns any rights,
 remedies, obligations or liabilities under or by reason of this Agreement, except as expressly provided in this Agreement. Neither
 party may assign its rights or obligations under this Agreement without the prior written consent of the other party; *provided*, *however*, that the Agent may assign its rights and obligations hereunder to an affiliate thereof without obtaining
 the Company's consent.

15. <u>Adjustments for Stock Splits</u>. The parties acknowledge and agree that all share-related numbers contained in this Agreement shall be adjusted
 to take into account any stock split, stock dividend or similar event effected with respect to the Common Stock.

16. <u>Entire Agreement; Amendment; Severability; Waiver</u>. This Agreement (including all schedules and exhibits attached hereto, and Placement
 Notices issued pursuant hereto, any contemporaneous side letters and any prior engagement letters between the Company and either
 of the Agents) constitutes the entire agreement and supersedes all other prior and contemporaneous agreements and undertakings, both
 written and oral, among the parties hereto with regard to the subject matter hereof. Neither this Agreement nor any term hereof may
 be amended except pursuant to a written instrument executed by the Company and the Agent. No waiver of any provision of this
 Agreement shall be effective unless in a written instrument executed by the party against whom such waiver is to be effective. In
 the event that any one or more of the provisions contained herein, or the application thereof in any circumstance, is held invalid,
 illegal or unenforceable as written by a court of competent jurisdiction, then such provision shall be given full force and effect
 to the fullest possible extent that it is valid, legal and enforceable, and the remainder of the terms and provisions herein shall
 be construed as if such invalid, illegal or unenforceable term or provision was not contained herein, but only to the extent that
 giving effect to such provision and the remainder of the terms and provisions hereof shall be in accordance with the intent of the
 parties as reflected in this Agreement. No implied waiver by a party shall arise in the absence of a waiver in writing signed by
 such party. No failure or delay in exercising any right, power, or privilege hereunder shall operate as a waiver thereof, nor shall
 any single or partial exercise thereof preclude any other or further exercise thereof or the exercise of any right, power, or privilege
 hereunder.

17.  **<u>GOVERNING LAW AND TIME; WAIVER OF JURY TRIAL</u>. THIS AGREEMENT SHALL BE GOVERNED BY AND CONSTRUED IN ACCORDANCE WITH THE LAWS OF THE STATE OF NEW YORK WITHOUT REGARD TO THE PRINCIPLES OF CONFLICTS OF LAWS. SPECIFIED TIMES OF DAY REFER TO NEW YORK CITY TIME. EACH PARTY HEREBY IRREVOCABLY WAIVES, TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, ANY AND ALL RIGHT TO TRIAL BY JURY IN ANY LEGAL PROCEEDING ARISING OUT OF OR RELATING TO THIS AGREEMENT OR THE TRANSACTIONS CONTEMPLATED HEREBY.** 

18.  **<u>CONSENT TO JURISDICTION</u>. EACH PARTY HEREBY IRREVOCABLY SUBMITS TO THE EXCLUSIVE JURISDICTION OF THE STATE AND FEDERAL COURTS SITTING IN THE CITY OF NEW YORK, BOROUGH OF MANHATTAN, FOR THE ADJUDICATION OF ANY DISPUTE HEREUNDER OR IN CONNECTION WITH ANY TRANSACTION CONTEMPLATED HEREBY, AND HEREBY IRREVOCABLY WAIVES, AND AGREES NOT TO ASSERT IN ANY SUIT, ACTION OR PROCEEDING, ANY CLAIM THAT IT IS NOT PERSONALLY SUBJECT TO THE JURISDICTION OF ANY SUCH COURT, THAT SUCH SUIT, ACTION OR PROCEEDING IS BROUGHT IN AN INCONVENIENT FORUM OR THAT THE VENUE OF SUCH SUIT, ACTION OR PROCEEDING IS IMPROPER. EACH PARTY HEREBY IRREVOCABLY WAIVES PERSONAL SERVICE OF PROCESS AND CONSENTS TO PROCESS BEING SERVED IN ANY SUCH SUIT, ACTION OR PROCEEDING BY MAILING A COPY THEREOF (CERTIFIED OR REGISTERED MAIL, RETURN RECEIPT REQUESTED) TO SUCH PARTY AT THE ADDRESS IN EFFECT FOR NOTICES TO IT UNDER THIS AGREEMENT AND AGREES THAT SUCH SERVICE SHALL CONSTITUTE GOOD AND SUFFICIENT SERVICE OF PROCESS AND NOTICE THEREOF. NOTHING CONTAINED HEREIN SHALL BE DEEMED TO LIMIT IN ANY WAY ANY RIGHT TO SERVE PROCESS IN ANY MANNER PERMITTED BY LAW.** 

19. <u>Counterparts</u>.
 This Agreement may be executed in two or more counterparts, each of which shall be deemed an original, but all of which together
 shall constitute one and the same instrument. Delivery of an executed Agreement by one party to the other may be made by facsimile,
 electronic mail (including any electronic signature covered by the U.S. federal ESIGN Act of 2000, Uniform Electronic Transactions
 Act, the Electronic Signatures and Records Act or other applicable law, e.g., www.docusign.com) or other transmission method and
 any counterpart so delivered shall be deemed to have been duly and validly delivered and be valid and effective for all purposes.

20. <u>Construction</u>.
 The section and exhibit headings herein are for convenience only and shall not affect the construction hereof. References herein
 to any law, statute, ordinance, code, regulation, rule or other requirement of any Governmental Authority shall be deemed to refer
 to such law, statute, ordinance, code, regulation, rule or other requirement of any Governmental Authority as amended, reenacted,
 supplemented or superseded in whole or in part and in effect from time to time and also to all rules and regulations promulgated
 thereunder.

21. <u>Permitted Free Writing Prospectuses</u>. The Company represents, warrants and agrees that, unless it obtains the prior written consent of the
 Agents, and the Agent represents, warrants and agrees that, unless it obtains the prior written consent of the Company, it
 has not made and will not make any offer relating to the Placement Shares that would constitute an Issuer Free Writing Prospectus,
 or that would otherwise constitute a "free writing prospectus," as defined in Rule 405, required to be filed with the
 Commission. Any such free writing prospectus consented to by the Agents or by the Company, as the case may be, is hereinafter referred
 to as a "Permitted Free Writing Prospectus." The Company represents and warrants that it has treated and agrees that
 it will treat each Permitted Free Writing Prospectus as an "issuer free writing prospectus," as defined in Rule 433,
 and has complied and will comply with the requirements of Rule 433 applicable to any Permitted Free Writing Prospectus, including
 timely filing with the Commission where required, legending and record keeping. For the purposes of clarity, the parties hereto agree
 that all free writing prospectuses, if any, listed in <u>Exhibit 21</u> hereto are Permitted Free Writing Prospectuses.

22. <u>Absence of Fiduciary Relationship</u>. The Company acknowledges and agrees that:

(a) the Agent is acting solely as agent in connection with the public offering of the Placement Shares and in connection with each transaction
 contemplated by this Agreement and the process leading to such transactions, and no fiduciary or advisory relationship between the
 Company or any of its respective affiliates, stockholders (or other equity holders), creditors or employees or any other party, on
 the one hand, and the Agents, on the other hand, has been or will be created in respect of any of the transactions contemplated by
 this Agreement, irrespective of whether or not any Agent has advised or is advising the Company on other matters, and the Agents
 have no obligation to the Company with respect to the transactions contemplated by this Agreement except the obligations expressly
 set forth in this Agreement;

(b) it
 is capable of evaluating and understanding, and understands and accepts, the terms, risks and conditions of the transactions contemplated
 by this Agreement;

(c) neither
 of the Agents nor their respective affiliates have provided any legal, accounting, regulatory or tax advice with respect to the transactions
 contemplated by this Agreement and it has consulted its own legal, accounting, regulatory and tax advisors to the extent it has deemed
 appropriate;

(d) it
 is aware that the Agent and its affiliates are engaged in a broad range of transactions which may involve interests that
 differ from those of the Company and such Agent and its affiliates have no obligation to disclose such interests and transactions
 to the Company by virtue of any fiduciary, advisory or agency relationship or otherwise; and

(e) it
 waives, to the fullest extent permitted by law, any claims it may have against the Agent or its affiliates for breach of
 fiduciary duty or alleged breach of fiduciary duty in connection with the sale of Placement Shares under this Agreement and agrees
 that such Agent and its affiliates shall not have any liability (whether direct or indirect, in contract, tort or otherwise) to the
 Company in respect of such a fiduciary duty claim or to any person asserting a fiduciary duty claim on its behalf or in right of
 the Company, including stockholders, employees or creditors of the Company.

23. <u>Definitions</u>.
 As used in this Agreement, the following terms have the respective meanings set forth below:

"**<u>Applicable Time</u>**" means (i) each Representation Date, (ii) the time of each sale of any Placement Shares pursuant to this Agreement and (iii) each Settlement Date.

"**<u>Governmental Authority</u>**" means (i) any federal, provincial, state, local, municipal, national or international government or governmental authority, regulatory or administrative agency, governmental commission, department, board, bureau, agency or instrumentality, court, tribunal, arbitrator or arbitral body (public or private); (ii) any self-regulatory organization; or (iii) any political subdivision of any of the foregoing.

"**<u>Issuer Free Writing Prospectus</u>**" means any "issuer free writing prospectus," as defined in Rule 433, relating to the Placement Shares that (1) is required to be filed with the Commission by the Company, (2) is a "road show" that is a "written communication" within the meaning of Rule 433(d)(8)(i) whether or not required to be filed with the Commission, or (3) is exempt from filing pursuant to Rule 433(d)(5)(i) because it contains a description of the Placement Shares or of the offering that does not reflect the final terms, in each case in the form filed or required to be filed with the Commission or, if not required to be filed, in the form retained in the Company's records pursuant to Rule 433(g) under the Securities Act Regulations.

"**<u>Rule 164</u>**," "**<u>Rule 172</u>**," "**<u>Rule 405</u>**," "**<u>Rule 415</u>**," "**<u>Rule 424</u>**," "**<u>Rule 424(b)</u>**," "**<u>Rule 430B</u>**," and "**<u>Rule 433</u>**" refer to such rules under the Securities Act Regulations.

All references in this Agreement to financial statements and schedules and other information that is "contained," "included" or "stated" in the Registration Statement or the Prospectus (and all other references of like import) shall be deemed to mean and include all such financial statements and schedules and other information that is incorporated by reference into the Registration Statement or the Prospectus, as the case may be.

All references in this Agreement to the Registration Statement, the Prospectus or any amendment or supplement to any of the foregoing shall be deemed to include the copy filed with the Commission pursuant to EDGAR; all references in this Agreement to any Issuer Free Writing Prospectus (other than any Issuer Free Writing Prospectuses that, pursuant to Rule 433, are not required to be filed with the Commission) shall be deemed to include the copy thereof filed with the Commission pursuant to EDGAR; and all references in this Agreement to "supplements" to the Prospectus shall include, without limitation, any supplements, "wrappers" or similar materials prepared in connection with any offering, sale or private placement of any Placement Shares by the Agents outside of the United States.

[***Signature Page Follows***]

If the foregoing correctly sets forth the understanding between the Company and the Agent, please so indicate in the space provided below for that purpose, whereupon this Agreement shall constitute a binding agreement between the Company and the Agent.

---

| | |
|:---|:---|
| Very truly yours, | Very truly yours, |
| EIGHTCO HOLDINGS INC. | EIGHTCO HOLDINGS INC. |
| By: | */s/ Kevin O'Donnell* |
| Name: | Kevin O'Donnell |
| Title: | Chief Executive Officer |

---

---

| | |
|:---|:---|
| R.F. LAFFERTY & CO., INC. | R.F. LAFFERTY & CO., INC. |
| By: | */s/ Rob Hackel* |
| Name: | Rob Hackel |
| Title: | Chief Operating Officer |

---

*[Signature Page to Sales Agreement]*

**SCHEDULE 1**

**Form of Placement Notice**

From: Eightco Holdings Inc.

To: R.F. Lafferty & Co., Inc.

 Attention: Robert Hackel (rhackel@rflafferty.com)

Subject: Placement Notice

Date: [●], 202[●]

Pursuant to the terms and subject to the conditions contained in the Sales Agreement by and between Eightco Holdings Inc., a Delaware corporation (the "**<u>Company</u>**") and R.F. Lafferty & Co., Inc., dated September [●], 2025, the Company hereby requests that R.F. Lafferty & Co., Inc. sell up to [●] shares of the Company's common stock, par value $0.001 per share, at a minimum market price of $[●] per share, during the time period beginning [month, day, time] and ending [month, day, time].

Very truly yours,

**SCHEDULE 2**

**Compensation**

The Company shall pay to the Agent in cash, upon each sale of Placement Shares pursuant to this Agreement, an amount up to 3.0% of the aggregate gross proceeds from each sale of Placement Shares.

**SCHEDULE 3**

**Notice Parties**

<u>The Company</u>

Eightco Holdings Inc.

101 Larry Holmes Dr., Suite 313

Easton, Pennsylvania 18042

Telephone: (888) 765-8933

Attention: Kevin O'Donnell

Email: ko@8co.holdings

<u>R.F. Lafferty & Co., Inc.</u>

Robert Hackel (rhackel@rflafferty.com)

**SCHEDULE 4**

**Subsidiaries**

Incorporated by reference to Exhibit 21 of the Company's most recently filed Annual Report on Form 10-K.

**Form of Representation Date Certificate Pursuant to Section 7(l)**

The undersigned, the duly qualified and elected [●], of Eightco Holdings Inc., a Delaware corporation (the "<u>Company</u>"), does hereby certify in such capacity and on behalf of the Company, pursuant to <u>Section 7(l)</u> of the Sales Agreement, dated September [●], 2025 (the "<u>Sales Agreement</u>"), by and between the Company and R.F. Lafferty & Co., Inc., that to the best of the knowledge of the undersigned:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) The representations and warranties of the Company in <u>Section 6</u> of the Sales Agreement are true and correct on and as of the date hereof with the same force and effect as if expressly made on and as of the date hereof, except for those representations and warranties that speak solely as of a specific date and which were true and correct as of such date; *provided*, *however*, that such representations and warranties shall be qualified by the disclosure included in or incorporated by reference into the Registration Statement and Prospectus; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) The Company has complied with all agreements and satisfied all conditions on its part to be performed or satisfied pursuant to the Sales Agreement at or prior to the date hereof.

Capitalized terms used herein without definition shall have the meanings given to such terms in the Sales Agreement.

---

| |
|:---|
| **EIGHTCO HOLDINGS INC.** |
| By: |
| Name: |
| Title: |

---

Date: [●]

**Form of Legal Opinion Pursuant to Section 7(m)**

Capitalized terms used and not defined herein shall have the meanings ascribed to them in the Sales Agreement.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1. The Company has been duly incorporated and is validly existing as a corporation in good standing under the laws of the State of Delaware. The Company has the corporate power and authority to own, lease and operate its properties and assets and to carry on its business as now conducted (as described in the Registration Statement and the Prospectus).

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2. The Sales Agreement has been duly and validly authorized, executed and delivered by the Company.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3. The Placement Shares have been duly authorized and, when issued and paid for pursuant to the terms of the Sales Agreement, will be validly issued, fully paid and nonassessable and free of any preemptive rights arising by operation of the General Corporation Law of the State of Delaware (the "DGCL") or rights of first refusal or other similar rights to subscribe for the Placement Shares pursuant to the Company's certificate of incorporation, bylaws or the DGCL, or under any material agreement listed in the exhibit index to (i) the Annual Report on Form 10-K (the "Form 10-K"), (ii) a Quarterly Report on Form 10-Q filed after the Form 10-K, or (iii) a Current Report on Form 8-K filed after the Form 10-K (a "Material Agreement").

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4. The Registration Statement filed with the Commission (No. 333-[__]) which registers the sale of the Placement Shares is currently effective under the Securities Act of 1933, as amended (the "Securities Act"), and no stop order suspending the effectiveness of the Registration Statement under the Securities Act has been issued and no proceedings for that purpose have been instituted or, to our knowledge, threatened. Any required filing of the Prospectus pursuant to Rule 424(b) under the Securities Act has been made in the manner and within the time required by Rule 424(b).

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5. The Registration Statement and the Prospectus (other than the financial statements and schedules and other financial data included or incorporated by reference therein, as to which we express no opinion), complied as of their respective effective or filing dates in all material respects as to form with the requirements of the Securities Act and the rules and regulations of the Commission promulgated thereunder.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6. Each of the Incorporated Documents, when it was filed with the Commission, complied as to form in all material respects with the requirements of the Exchange Act and the rules and regulations of the Commission promulgated thereunder.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7. The execution, delivery and performance by the Company of, and the compliance by the Company with the terms of, the Sales Agreement and the issuance, sale and delivery of the Placement Shares pursuant to the Sales Agreement do not (a) conflict with or result in a violation of any provision of law, rule or regulation or any rule or regulation of any securities exchange applicable to the Company or of the certificate of incorporation or bylaws of the Company, (b) conflict with, result in a breach of or constitute a default (or an event which with notice or lapse of time or both would become a default) under, or result in or permit the termination or modification of, a Material Agreement, (c) conflict with or result in any breach or violation of or constitute a default under any order, writ, judgment or decree known to us to which the Company is a party or is subject, or (d) to our knowledge, result in the creation or imposition of any lien, claim or encumbrance on any of the assets or properties of the Company.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;8. To our knowledge, except as set forth in the Company's filings with the Commission, there is (i) no claim, action, suit, proceeding, arbitration, investigation or inquiry, pending or threatened, before any Governmental Authority, against the Company, or any of its officers, directors or employees (in connection with the discharge of their duties as officers, directors and employees), of the Company, or affecting any of its properties or assets and (ii) no indenture, contract, lease, mortgage, deed of trust, note agreement, loan or other agreement or instrument of a character required to be filed as an exhibit to the Registration Statement, which is not filed as required by the Securities Act and the rules thereunder.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;9. In connection with the valid execution, delivery and performance by the Company of the Sales Agreement, or the offer, sale, issuance or delivery of the Placement Shares or the consummation of the transactions contemplated thereby, no consent, license, permit, waiver, approval or authorization of, or designation, declaration, registration or filing with, any Governmental Authority is required, other than registration pursuant to the Securities Act and approval for listing of the Placement Shares on the Exchange.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;10. The Company is not, and after giving effect to the offering and sale of the Placement Shares and the application of the proceeds thereof as described in the Prospectus will not be, required to register as an Investment Company within the meaning of the Investment Company Act of 1940, as amended.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;11. The information included in the Registration Statement and the Prospectus under the captions "[Description of Capital Stock]" and "[Material U.S. Federal Tax Consequences"] to the extent that each of them constitutes matters of law, summaries of legal matters, documents referred to therein or legal conclusions, have been reviewed by us and fairly summarize the matters set forth therein in all material respects.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;12. Except as set forth in the Registration Statement and the Prospectus, no holders of securities of the Company have rights to require the registration under the Securities Act of resales of such securities under any Material Agreement.

The opinion of counsel will be accompanied by a standard Rule 10b-5 negative assurance letter, including the following:

Based on our participation, review and reliance as described above, we advise you that no facts came to our attention that caused us to believe that:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;● the Registration Statement, as of its most recent effective date, including the information deemed to be a part of the Registration Statement pursuant to Rule 430B under the Securities Act (together with the Incorporated Documents at that time), contained an untrue statement of a material fact or omitted to state a material fact required to be stated therein or necessary to make the statements therein not misleading; or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;● the Prospectus, as of its date or as of the date hereof (together with the Incorporated Documents at those dates), contained or contains an untrue statement of a material fact or omitted or omits to state a material fact necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading; it being understood that we express no belief with respect to the financial statements and schedules, or other financial or accounting data included in or incorporated by reference into, or omitted from, the Registration Statement, the Prospectus or the Incorporated Documents.

**<u>Exhibit 21</u>**

**Permitted Free Writing Prospectus**

None.

## Exhibit 5.1

**Exhibit 5.1**

![](ex5-1_001.jpg)

September 10, 2025

Eightco Holdings Inc.

101 Larry Holmes Drive, Suite 313

Easton, PA 18042

Re: <u>Sales Agreement</u>

Ladies and Gentlemen:

We have acted as counsel to Eightco Holdings Inc., a Delaware corporation (the "***Company***"), in connection with the preparation and filing with the Securities and Exchange Commission (the "***Commission***") under the Securities Act of 1933, as amended (the "***Securities Act***"), of (i) the registration statement on Form S-3ASR (the "***Registration Statement***") initially filed with the Commission on September 10, 2025, (ii) the base prospectus dated September 10, 2025, forming a part of the Registration Statement (the "***Base Prospectus***") and (iii) the prospectus supplement dated September 10, 2025 contained in the Registration Statement (together with the Base Prospectus, the "***Prospectus Supplement***") in connection with an "at the market offering" by the Company of shares of the Company's common stock, par value $0.001 per share, having an aggregate offering price of up to $2,700,000,000 (the "***Shares***"), covered by the Registration Statement. The Shares are being sold pursuant to a Sales Agreement, dated September 10, 2025 (the "***Sales Agreement***"), by and between the Company and R.F. Lafferty & Co., Inc., as the Sales Agent ("***Sales Agent***"). We understand that the Shares are to be offered and sold in the manner described in the Prospectus Supplement. This opinion is being delivered in accordance with the requirements of Item 601(b)(5) of Regulation S-K promulgated under the Securities Act.

In rendering the opinion set forth below, we have examined and relied upon such certificates, corporate records, agreements, instruments and other documents that we considered necessary or appropriate as a basis for the opinion, including (i) the Registration Statement, (ii) the Prospectus Supplement, (iii) the Sales Agreement, (iv) resolutions adopted by the Board of Directors of the Company on September 9, 2025, (v) the certificate of incorporation of the Company and all amendments thereto and the bylaws of the Company, in each case, as in effect on the date hereof, (vi) a certificate of good standing from the Secretary of State of the State of Delaware as to the Company, dated as of a recent date, (vii) an officer's certificate, dated as of the date hereof, of the Chief Executive Officer of the Company, and (viii) such other laws, records, documents, certificates, opinions, and instruments as we have deemed necessary to render this opinion.

September 10, 2025

In our examination, we have assumed the legal capacity of all natural persons, the genuineness of all signatures, the authenticity of all documents submitted to us as certified or photostatic copies, the authenticity of the originals of such latter documents and that the Sales Agreement constitutes the valid and binding obligation of each party thereto (other than the Company) enforceable against each such party in accordance with its terms. As to any facts material to this opinion that we did not independently establish or verify, we have relied upon oral or written statements and representations of officers and other representatives of the Company and others.

Based upon the foregoing and subject to the assumptions, qualifications and limitations set forth herein, we are of the opinion that the Shares have been duly authorized and, when the Shares are delivered against payment of the agreed consideration therefor in accordance with the Sales Agreement, the Shares will be validly issued, fully paid and nonassessable.

The foregoing opinion is limited to the General Corporation Law of the State of Delaware, as currently in effect. We express no opinion with respect to any other laws, statutes, regulations or ordinances.

We hereby consent to the filing of this opinion as an exhibit to the Company's Current Report on Form 8-K to be filed with the Commission on September 10, 2025 and its incorporation by reference into the Registration Statement and to the reference to our firm under the caption "Legal Matters" in the Prospectus Supplement included in the Registration Statement. In giving such consent, we do not concede that we are experts within the meaning of the Securities Act or the rules and regulations thereunder or that this consent is required by Section 7 of the Securities Act.

---

| |
|:---|
| Very truly yours,<br>|
| /s/ Winston & Strawn LLP |

---